Header Logo

Connection

David Bennett to Alzheimer Disease

This is a "connection" page, showing publications David Bennett has written about Alzheimer Disease.
Connection Strength

52.258
  1. Author Response: Estrogen Receptor Genes, Cognitive Decline, and Alzheimer Disease. Neurology. 2023 10 03; 101(14):634.
    View in: PubMed
    Score: 0.377
  2. Selective serotonin reuptake inhibitor use, age-related neuropathology and cognition in late-life. Psychiatry Res. 2023 10; 328:115471.
    View in: PubMed
    Score: 0.376
  3. Associations of VGF with Neuropathologies and Cognitive Health in Older Adults. Ann Neurol. 2023 08; 94(2):232-244.
    View in: PubMed
    Score: 0.368
  4. Trends in Postmortem Neurodegenerative and Cerebrovascular Neuropathologies Over 25 Years. JAMA Neurol. 2023 04 01; 80(4):370-376.
    View in: PubMed
    Score: 0.364
  5. Brain ?-Amyloid Links the Association of Change in Body Mass Index With Cognitive Decline in Community-Dwelling Older Adults. J Gerontol A Biol Sci Med Sci. 2023 02 24; 78(2):277-285.
    View in: PubMed
    Score: 0.362
  6. Estrogen Receptor Genes, Cognitive Decline, and Alzheimer Disease. Neurology. 2023 04 04; 100(14):e1474-e1487.
    View in: PubMed
    Score: 0.360
  7. Alzheimer's Disease Pathology Outside of the Cerebrum Is Related to a Higher Odds of Dementia. J Alzheimers Dis. 2023; 96(2):563-578.
    View in: PubMed
    Score: 0.358
  8. Frequency and Underlying Pathology of Pure Vascular Cognitive Impairment. JAMA Neurol. 2022 12 01; 79(12):1277-1286.
    View in: PubMed
    Score: 0.356
  9. Longitudinal change in serial position scores in older adults with entorhinal and hippocampal neuropathologies. J Int Neuropsychol Soc. 2023 Jul; 29(6):561-571.
    View in: PubMed
    Score: 0.350
  10. Association of AK4 Protein From Stem Cell-Derived Neurons With Cognitive Reserve: An Autopsy Study. Neurology. 2022 11 15; 99(20):e2264-e2274.
    View in: PubMed
    Score: 0.349
  11. Modifiable psychosocial risk factors and delayed onset of dementia in older populations: analysis of two prospective US cohorts. BMJ Open. 2022 04 04; 12(4):e059317.
    View in: PubMed
    Score: 0.340
  12. Neuropathologic Correlates of Human Cortical Proteins in Alzheimer Disease and Related Dementias. Neurology. 2022 03 08; 98(10):e1031-e1039.
    View in: PubMed
    Score: 0.334
  13. Relationship of Purpose in Life to Dementia in Older Black and White Brazilians. J Int Neuropsychol Soc. 2022 11; 28(10):997-1002.
    View in: PubMed
    Score: 0.330
  14. Reducing Your Risk of Alzheimer's Dementia: Building a Better Brain as We Age. Arch Clin Neuropsychol. 2021 Oct 13; 36(7):1257-1265.
    View in: PubMed
    Score: 0.329
  15. Aducanumab and the "post-amyloid" era of Alzheimer research? Neuron. 2021 10 06; 109(19):3045-3047.
    View in: PubMed
    Score: 0.328
  16. To what degree is late life cognitive decline driven by age-related neuropathologies? Brain. 2021 08 17; 144(7):2166-2175.
    View in: PubMed
    Score: 0.326
  17. Purpose in Life May Delay Adverse Health Outcomes in Old Age. Am J Geriatr Psychiatry. 2022 Feb; 30(2):174-181.
    View in: PubMed
    Score: 0.320
  18. Inhibitory Fc? Receptor and Paired Immunoglobulin Type 2 Receptor Alpha Genotypes in Alzheimer's Disease. J Alzheimers Dis. 2021; 84(3):965-968.
    View in: PubMed
    Score: 0.312
  19. Association of Early-Life Cognitive Enrichment With Alzheimer Disease Pathological Changes and Cognitive Decline. JAMA Neurol. 2020 10 01; 77(10):1217-1224.
    View in: PubMed
    Score: 0.307
  20. Representation of Older Latinxs in Cohort Studies at the Rush Alzheimer's Disease Center. Neuroepidemiology. 2020; 54(5):404-418.
    View in: PubMed
    Score: 0.305
  21. Extending Alzheimer disease biomarker studies into the Hispanic community. Neurology. 2020 10 13; 95(15):665-666.
    View in: PubMed
    Score: 0.304
  22. Physicians and Alzheimer Dementia: Past, Present, and Future. Ann Intern Med. 2020 05 19; 172(10):695-696.
    View in: PubMed
    Score: 0.298
  23. Genetic risk for Alzheimer's dementia predicts motor deficits through multi-omic systems in older adults. Transl Psychiatry. 2019 10 03; 9(1):241.
    View in: PubMed
    Score: 0.286
  24. Cognition may link cortical IGFBP5 levels with motor function in older adults. PLoS One. 2019; 14(8):e0220968.
    View in: PubMed
    Score: 0.283
  25. Alzheimer's disease frequency peaks in the tenth decade and is lower afterwards. Acta Neuropathol Commun. 2019 07 03; 7(1):104.
    View in: PubMed
    Score: 0.281
  26. Scam Awareness Related to Incident Alzheimer Dementia and Mild Cognitive Impairment: A Prospective Cohort Study. Ann Intern Med. 2019 05 21; 170(10):702-709.
    View in: PubMed
    Score: 0.277
  27. Physical activity, common brain pathologies, and cognition in community-dwelling older adults. Neurology. 2019 02 19; 92(8):e811-e822.
    View in: PubMed
    Score: 0.272
  28. Causes and Patterns of Dementia: An Update in the Era of Redefining Alzheimer's Disease. Annu Rev Public Health. 2019 04 01; 40:65-84.
    View in: PubMed
    Score: 0.272
  29. Attributable risk of Alzheimer's dementia attributed to age-related neuropathologies. Ann Neurol. 2019 01; 85(1):114-124.
    View in: PubMed
    Score: 0.271
  30. Sex differences in Alzheimer's disease and common neuropathologies of aging. Acta Neuropathol. 2018 12; 136(6):887-900.
    View in: PubMed
    Score: 0.268
  31. An MRI biomarker of mixed pathology. Neurology. 2018 10 09; 91(15):682-683.
    View in: PubMed
    Score: 0.266
  32. A multi-omic atlas of the human frontal cortex for aging and Alzheimer's disease research. Sci Data. 2018 08 07; 5:180142.
    View in: PubMed
    Score: 0.264
  33. Targeted brain proteomics uncover multiple pathways to Alzheimer's dementia. Ann Neurol. 2018 07; 84(1):78-88.
    View in: PubMed
    Score: 0.262
  34. APOE e2e4 genotype, incident AD and MCI, cognitive decline, and AD pathology in older adults. Neurology. 2018 06 12; 90(24):e2127-e2134.
    View in: PubMed
    Score: 0.260
  35. Alzheimer disease biomarkers and synucleinopathy. Neurology. 2018 03 20; 90(12):537-538.
    View in: PubMed
    Score: 0.256
  36. Lack of Benefit With Idalopirdine for Alzheimer Disease: Another Therapeutic Failure in a Complex Disease Process. JAMA. 2018 01 09; 319(2):123-125.
    View in: PubMed
    Score: 0.254
  37. Religious Orders Study and Rush Memory and Aging Project. J Alzheimers Dis. 2018; 64(s1):S161-S189.
    View in: PubMed
    Score: 0.253
  38. Association Between Brain Gene Expression, DNA Methylation, and Alteration of Ex Vivo Magnetic Resonance Imaging Transverse Relaxation in Late-Life Cognitive Decline. JAMA Neurol. 2017 12 01; 74(12):1473-1480.
    View in: PubMed
    Score: 0.252
  39. APOE e4-TOMM40 '523 haplotypes and the risk of Alzheimer's disease in older Caucasian and African Americans. PLoS One. 2017; 12(7):e0180356.
    View in: PubMed
    Score: 0.245
  40. Mixed pathologies and neural reserve: Implications of complexity for Alzheimer disease drug discovery. PLoS Med. 2017 Mar; 14(3):e1002256.
    View in: PubMed
    Score: 0.240
  41. A genome-wide profiling of brain DNA hydroxymethylation in Alzheimer's disease. Alzheimers Dement. 2017 Jun; 13(6):674-688.
    View in: PubMed
    Score: 0.237
  42. Ex vivo MRI transverse relaxation in community based older persons with and without Alzheimer's dementia. Behav Brain Res. 2017 03 30; 322(Pt B):233-240.
    View in: PubMed
    Score: 0.231
  43. Relation of genomic variants for Alzheimer disease dementia to common neuropathologies. Neurology. 2016 Aug 02; 87(5):489-96.
    View in: PubMed
    Score: 0.228
  44. Genetic variants in Alzheimer disease - molecular and brain network approaches. Nat Rev Neurol. 2016 07; 12(7):413-27.
    View in: PubMed
    Score: 0.227
  45. Methylation profiles in peripheral blood CD4+ lymphocytes versus brain: The relation to Alzheimer's disease pathology. Alzheimers Dement. 2016 09; 12(9):942-951.
    View in: PubMed
    Score: 0.224
  46. Alzheimer's disease: Unique markers for diagnosis & new treatment modalities. Indian J Med Res. 2015 Oct; 142(4):369-82.
    View in: PubMed
    Score: 0.217
  47. Reply to Itzhaki. J Infect Dis. 2015 Jun 15; 211(12):2024.
    View in: PubMed
    Score: 0.207
  48. Association of Brain DNA methylation in SORL1, ABCA7, HLA-DRB5, SLC24A4, and BIN1 with pathological diagnosis of Alzheimer disease. JAMA Neurol. 2015 Jan; 72(1):15-24.
    View in: PubMed
    Score: 0.206
  49. Author response. Neurology. 2014 Sep 30; 83(14):1302.
    View in: PubMed
    Score: 0.202
  50. Alzheimer's disease: early alterations in brain DNA methylation at ANK1, BIN1, RHBDF2 and other loci. Nat Neurosci. 2014 Sep; 17(9):1156-63.
    View in: PubMed
    Score: 0.201
  51. Cytomegalovirus infection and risk of Alzheimer disease in older black and white individuals. J Infect Dis. 2015 Jan 15; 211(2):230-7.
    View in: PubMed
    Score: 0.200
  52. Epigenomics of Alzheimer's disease. Transl Res. 2015 Jan; 165(1):200-20.
    View in: PubMed
    Score: 0.197
  53. Alzheimer's disease in African Americans: risk factors and challenges for the future. Health Aff (Millwood). 2014 Apr; 33(4):580-6.
    View in: PubMed
    Score: 0.195
  54. Contribution of Alzheimer disease to mortality in the United States. Neurology. 2014 Mar 25; 82(12):1045-50.
    View in: PubMed
    Score: 0.194
  55. Building a pipeline to discover and validate novel therapeutic targets and lead compounds for Alzheimer's disease. Biochem Pharmacol. 2014 Apr 15; 88(4):617-30.
    View in: PubMed
    Score: 0.193
  56. Modification of the relationship of the apolipoprotein E e4 allele to the risk of Alzheimer disease and neurofibrillary tangle density by sleep. JAMA Neurol. 2013 Dec; 70(12):1544-51.
    View in: PubMed
    Score: 0.191
  57. A 2-process model for neuropathology of Alzheimer's disease. Neurobiol Aging. 2014 Feb; 35(2):301-8.
    View in: PubMed
    Score: 0.189
  58. Genetic susceptibility for Alzheimer disease neuritic plaque pathology. JAMA Neurol. 2013 Sep 01; 70(9):1150-7.
    View in: PubMed
    Score: 0.188
  59. APOE e4, Alzheimer's disease pathology, cerebrovascular disease, and cognitive change over the years prior to death. Psychol Aging. 2013 Dec; 28(4):1015-23.
    View in: PubMed
    Score: 0.183
  60. Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease. Neurology. 2013 Feb 12; 80(7):690.
    View in: PubMed
    Score: 0.181
  61. Cognitive impairment, decline and fluctuations in older community-dwelling subjects with Lewy bodies. Brain. 2012 Oct; 135(Pt 10):3005-14.
    View in: PubMed
    Score: 0.176
  62. The natural history of cognitive decline in Alzheimer's disease. Psychol Aging. 2012 Dec; 27(4):1008-17.
    View in: PubMed
    Score: 0.175
  63. Poor decision making is a consequence of cognitive decline among older persons without Alzheimer's disease or mild cognitive impairment. PLoS One. 2012; 7(8):e43647.
    View in: PubMed
    Score: 0.175
  64. A random change point model for cognitive decline in Alzheimer's disease and mild cognitive impairment. Neuroepidemiology. 2012; 39(2):73-83.
    View in: PubMed
    Score: 0.174
  65. Overview and findings from the religious orders study. Curr Alzheimer Res. 2012 Jul; 9(6):628-45.
    View in: PubMed
    Score: 0.173
  66. Overview and findings from the rush Memory and Aging Project. Curr Alzheimer Res. 2012 Jul; 9(6):646-63.
    View in: PubMed
    Score: 0.173
  67. Longitudinal epidemiologic clinical-pathologic studies of aging and Alzheimer's disease. Curr Alzheimer Res. 2012 Jul; 9(6):617-20.
    View in: PubMed
    Score: 0.173
  68. Alzheimer's disease can spare local metacognition despite global anosognosia: revisiting the confidence-accuracy relationship in episodic memory. Neuropsychologia. 2012 Jul; 50(9):2356-64.
    View in: PubMed
    Score: 0.173
  69. Cognitive reserve, presynaptic proteins and dementia in the elderly. Transl Psychiatry. 2012 May 15; 2:e114.
    View in: PubMed
    Score: 0.171
  70. Cellular, synaptic, and biochemical features of resilient cognition in Alzheimer's disease. Neurobiol Aging. 2013 Jan; 34(1):157-68.
    View in: PubMed
    Score: 0.171
  71. Effect of purpose in life on the relation between Alzheimer disease pathologic changes on cognitive function in advanced age. Arch Gen Psychiatry. 2012 May; 69(5):499-505.
    View in: PubMed
    Score: 0.171
  72. Total daily physical activity and the risk of AD and cognitive decline in older adults. Neurology. 2012 Apr 24; 78(17):1323-9.
    View in: PubMed
    Score: 0.171
  73. The CETP I405V polymorphism is associated with an increased risk of Alzheimer's disease. Aging Cell. 2012 Apr; 11(2):228-33.
    View in: PubMed
    Score: 0.167
  74. Life space and risk of Alzheimer disease, mild cognitive impairment, and cognitive decline in old age. Am J Geriatr Psychiatry. 2011 Nov; 19(11):961-9.
    View in: PubMed
    Score: 0.165
  75. Harm avoidance and risk of Alzheimer's disease. Psychosom Med. 2011 Oct; 73(8):690-6.
    View in: PubMed
    Score: 0.164
  76. Hemoglobin level in older persons and incident Alzheimer disease: prospective cohort analysis. Neurology. 2011 Jul 19; 77(3):219-26.
    View in: PubMed
    Score: 0.162
  77. Loss of motor function in preclinical Alzheimer's disease. Expert Rev Neurother. 2011 May; 11(5):665-76.
    View in: PubMed
    Score: 0.160
  78. Vulnerability to stress, anxiety, and development of dementia in old age. Am J Geriatr Psychiatry. 2011 Apr; 19(4):327-34.
    View in: PubMed
    Score: 0.159
  79. Cognitive decline in prodromal Alzheimer disease and mild cognitive impairment. Arch Neurol. 2011 Mar; 68(3):351-6.
    View in: PubMed
    Score: 0.158
  80. Heritability of different forms of memory in the Late Onset Alzheimer's Disease Family Study. J Alzheimers Dis. 2011; 23(2):249-55.
    View in: PubMed
    Score: 0.156
  81. Sources of variability in estimates of the prevalence of Alzheimer's disease in the United States. Alzheimers Dement. 2011 Jan; 7(1):74-9.
    View in: PubMed
    Score: 0.156
  82. Is there a link between cancer and Alzheimer disease? Neurology. 2010 Sep 28; 75(13):1216-7.
    View in: PubMed
    Score: 0.153
  83. Loss of basic lexical knowledge in old age. J Neurol Neurosurg Psychiatry. 2011 Apr; 82(4):369-72.
    View in: PubMed
    Score: 0.152
  84. False recollection of emotional pictures in Alzheimer's disease. Neuropsychologia. 2010 Oct; 48(12):3614-8.
    View in: PubMed
    Score: 0.152
  85. Effect of a purpose in life on risk of incident Alzheimer disease and mild cognitive impairment in community-dwelling older persons. Arch Gen Psychiatry. 2010 Mar; 67(3):304-10.
    View in: PubMed
    Score: 0.147
  86. Is there a link between cancer and Alzheimer disease? Neurology. 2010 Jan 12; 74(2):100-1.
    View in: PubMed
    Score: 0.145
  87. Association of muscle strength with the risk of Alzheimer disease and the rate of cognitive decline in community-dwelling older persons. Arch Neurol. 2009 Nov; 66(11):1339-44.
    View in: PubMed
    Score: 0.144
  88. The neuropathology of probable Alzheimer disease and mild cognitive impairment. Ann Neurol. 2009 Aug; 66(2):200-8.
    View in: PubMed
    Score: 0.141
  89. Olfactory impairment in presymptomatic Alzheimer's disease. Ann N Y Acad Sci. 2009 Jul; 1170:730-5.
    View in: PubMed
    Score: 0.141
  90. Neuropathologic intermediate phenotypes enhance association to Alzheimer susceptibility alleles. Neurology. 2009 Apr 28; 72(17):1495-503.
    View in: PubMed
    Score: 0.139
  91. NSAID exposure and risk of Alzheimer disease: is timing everything? Neurology. 2009 Jun 02; 72(22):1884-5.
    View in: PubMed
    Score: 0.139
  92. Physical frailty in older persons is associated with Alzheimer disease pathology. Neurology. 2008 Aug 12; 71(7):499-504.
    View in: PubMed
    Score: 0.132
  93. Relation of NSAIDs to incident AD, change in cognitive function, and AD pathology. Neurology. 2008 Jun 03; 70(23):2219-25.
    View in: PubMed
    Score: 0.130
  94. Change in depressive symptoms during the prodromal phase of Alzheimer disease. Arch Gen Psychiatry. 2008 Apr; 65(4):439-45.
    View in: PubMed
    Score: 0.129
  95. Processing resources reduce the effect of Alzheimer pathology on other cognitive systems. Neurology. 2008 Apr 22; 70(17):1534-42.
    View in: PubMed
    Score: 0.129
  96. Plaque complement activation and cognitive loss in Alzheimer's disease. J Neuroinflammation. 2008 Mar 11; 5:9.
    View in: PubMed
    Score: 0.128
  97. Levels of estrogen receptors alpha and beta in frontal cortex of patients with Alzheimer's disease: relationship to Mini-Mental State Examination scores. Curr Alzheimer Res. 2008 Feb; 5(1):45-51.
    View in: PubMed
    Score: 0.127
  98. Statins, incident Alzheimer disease, change in cognitive function, and neuropathology. Neurology. 2008 May 06; 70(19 Pt 2):1795-802.
    View in: PubMed
    Score: 0.127
  99. Grip strength and the risk of incident Alzheimer's disease. Neuroepidemiology. 2007; 29(1-2):66-73.
    View in: PubMed
    Score: 0.125
  100. Conscientiousness and the incidence of Alzheimer disease and mild cognitive impairment. Arch Gen Psychiatry. 2007 Oct; 64(10):1204-12.
    View in: PubMed
    Score: 0.124
  101. Subcortical infarcts, Alzheimer's disease pathology, and memory function in older persons. Ann Neurol. 2007 Jul; 62(1):59-66.
    View in: PubMed
    Score: 0.122
  102. Relation of cognitive activity to risk of developing Alzheimer disease. Neurology. 2007 Nov 13; 69(20):1911-20.
    View in: PubMed
    Score: 0.122
  103. Frailty is associated with incident Alzheimer's disease and cognitive decline in the elderly. Psychosom Med. 2007 Jun; 69(5):483-9.
    View in: PubMed
    Score: 0.122
  104. Loneliness and risk of Alzheimer disease. Arch Gen Psychiatry. 2007 Feb; 64(2):234-40.
    View in: PubMed
    Score: 0.119
  105. Body mass index in older persons is associated with Alzheimer disease pathology. Neurology. 2006 Dec 12; 67(11):1949-54.
    View in: PubMed
    Score: 0.118
  106. Diabetes is related to cerebral infarction but not to AD pathology in older persons. Neurology. 2006 Dec 12; 67(11):1960-5.
    View in: PubMed
    Score: 0.118
  107. Motor dysfunction in mild cognitive impairment and the risk of incident Alzheimer disease. Arch Neurol. 2006 Dec; 63(12):1763-9.
    View in: PubMed
    Score: 0.118
  108. Memory complaints are related to Alzheimer disease pathology in older persons. Neurology. 2006 Nov 14; 67(9):1581-5.
    View in: PubMed
    Score: 0.117
  109. Decision rules guiding the clinical diagnosis of Alzheimer's disease in two community-based cohort studies compared to standard practice in a clinic-based cohort study. Neuroepidemiology. 2006; 27(3):169-76.
    View in: PubMed
    Score: 0.116
  110. Association of daytime napping and Parkinsonian signs in Alzheimer's disease. Sleep Med. 2006 Dec; 7(8):614-8.
    View in: PubMed
    Score: 0.116
  111. The relationship between cerebral Alzheimer's disease pathology and odour identification in old age. J Neurol Neurosurg Psychiatry. 2007 Jan; 78(1):30-5.
    View in: PubMed
    Score: 0.116
  112. Chronic psychological distress and risk of Alzheimer's disease in old age. Neuroepidemiology. 2006; 27(3):143-53.
    View in: PubMed
    Score: 0.116
  113. Mild cognitive impairment: risk of Alzheimer disease and rate of cognitive decline. Neurology. 2006 Aug 08; 67(3):441-5.
    View in: PubMed
    Score: 0.115
  114. Postmortem indices linking risk factors to cognition: results from the Religious Order Study and the Memory and Aging Project. Alzheimer Dis Assoc Disord. 2006 Jul-Sep; 20(3 Suppl 2):S63-8.
    View in: PubMed
    Score: 0.114
  115. Neuropathology of older persons without cognitive impairment from two community-based studies. Neurology. 2006 Jun 27; 66(12):1837-44.
    View in: PubMed
    Score: 0.114
  116. The effect of social networks on the relation between Alzheimer's disease pathology and level of cognitive function in old people: a longitudinal cohort study. Lancet Neurol. 2006 May; 5(5):406-12.
    View in: PubMed
    Score: 0.113
  117. Mild cognitive impairment in different functional domains and incident Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2005 Nov; 76(11):1479-84.
    View in: PubMed
    Score: 0.109
  118. Relation of blood pressure to risk of incident Alzheimer's disease and change in global cognitive function in older persons. Neuroepidemiology. 2006; 26(1):30-6.
    View in: PubMed
    Score: 0.109
  119. Change in body mass index and risk of incident Alzheimer disease. Neurology. 2005 Sep 27; 65(6):892-7.
    View in: PubMed
    Score: 0.108
  120. Education modifies the association of amyloid but not tangles with cognitive function. Neurology. 2005 Sep 27; 65(6):953-5.
    View in: PubMed
    Score: 0.108
  121. Amyloid mediates the association of apolipoprotein E e4 allele to cognitive function in older people. J Neurol Neurosurg Psychiatry. 2005 Sep; 76(9):1194-9.
    View in: PubMed
    Score: 0.108
  122. Implicit memory and Alzheimer's disease neuropathology. Brain. 2005 Sep; 128(Pt 9):2006-15.
    View in: PubMed
    Score: 0.106
  123. Sex differences in the clinical manifestations of Alzheimer disease pathology. Arch Gen Psychiatry. 2005 Jun; 62(6):685-91.
    View in: PubMed
    Score: 0.106
  124. Mild cognitive impairment: is it Alzheimer's disease or not? J Alzheimers Dis. 2005 Jun; 7(3):241-5; discussion 255-62.
    View in: PubMed
    Score: 0.106
  125. Early life socioeconomic status and late life risk of Alzheimer's disease. Neuroepidemiology. 2005; 25(1):8-14.
    View in: PubMed
    Score: 0.105
  126. Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions. Neurology. 2005 Mar 08; 64(5):834-41.
    View in: PubMed
    Score: 0.104
  127. The apolipoprotein E epsilon4 allele and incident Alzheimer's disease in persons with mild cognitive impairment. Neurocase. 2005 Feb; 11(1):3-7.
    View in: PubMed
    Score: 0.104
  128. Immunization therapy for Alzheimer disease? Neurology. 2005 Jan 11; 64(1):10-2.
    View in: PubMed
    Score: 0.103
  129. Relationship between Alzheimer's disease clinical stage and Gq/11 in subcellular fractions of frontal cortex. J Neural Transm (Vienna). 2005 Aug; 112(8):1049-56.
    View in: PubMed
    Score: 0.102
  130. Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. Arch Neurol. 2004 May; 61(5):661-6.
    View in: PubMed
    Score: 0.098
  131. Cerebral infarctions and the likelihood of dementia from Alzheimer disease pathology. Neurology. 2004 Apr 13; 62(7):1148-55.
    View in: PubMed
    Score: 0.098
  132. Neurofibrillary tangles mediate the association of amyloid load with clinical Alzheimer disease and level of cognitive function. Arch Neurol. 2004 Mar; 61(3):378-84.
    View in: PubMed
    Score: 0.097
  133. Mild cognitive impairment. Clin Geriatr Med. 2004 Feb; 20(1):15-25.
    View in: PubMed
    Score: 0.097
  134. Identification of Dementia in Medicare Claims Compared to Rigorous Clinical Assessments in African Americans. J Gerontol A Biol Sci Med Sci. 2024 Jan 01; 79(1).
    View in: PubMed
    Score: 0.096
  135. Proneness to psychological distress is associated with risk of Alzheimer's disease. Neurology. 2003 Dec 09; 61(11):1479-85.
    View in: PubMed
    Score: 0.096
  136. Cell-type-specific Alzheimer's disease polygenic risk scores are associated with distinct disease processes in Alzheimer's disease. Nat Commun. 2023 Nov 30; 14(1):7659.
    View in: PubMed
    Score: 0.095
  137. High-throughput digital quantification of Alzheimer disease pathology and associated infrastructure in large autopsy studies. J Neuropathol Exp Neurol. 2023 Nov 20; 82(12):976-986.
    View in: PubMed
    Score: 0.095
  138. Bone mineral density and the risk of incident dementia: A meta-analysis. J Am Geriatr Soc. 2024 Jan; 72(1):194-200.
    View in: PubMed
    Score: 0.095
  139. Dissecting the human leptomeninges at single-cell resolution. Nat Commun. 2023 11 03; 14(1):7036.
    View in: PubMed
    Score: 0.095
  140. Depressive symptoms, clinical AD, and cortical plaques and tangles in older persons. Neurology. 2003 Oct 28; 61(8):1102-7.
    View in: PubMed
    Score: 0.095
  141. Metformin, age-related cognitive decline, and brain pathology. Neurobiol Aging. 2024 Jan; 133:99-106.
    View in: PubMed
    Score: 0.095
  142. Associations of Sex, Race, and Apolipoprotein E Alleles With Multiple Domains of Cognition Among Older Adults. JAMA Neurol. 2023 09 01; 80(9):929-939.
    View in: PubMed
    Score: 0.094
  143. Relation of Motor Impairments to Neuropathologic Changes of Limbic-Predominant Age-Related TDP-43 Encephalopathy in Older Adults. Neurology. 2023 10 10; 101(15):e1542-e1553.
    View in: PubMed
    Score: 0.094
  144. Age-related and amyloid-beta-independent tau deposition and its downstream effects. Brain. 2023 08 01; 146(8):3192-3205.
    View in: PubMed
    Score: 0.093
  145. The Relationship of MRI-Derived Alzheimer's and Cerebrovascular-Related Signatures With Level of and Change in Health and Financial Literacy. Am J Geriatr Psychiatry. 2023 12; 31(12):1129-1139.
    View in: PubMed
    Score: 0.093
  146. Education modifies the relation of AD pathology to level of cognitive function in older persons. Neurology. 2003 Jun 24; 60(12):1909-15.
    View in: PubMed
    Score: 0.093
  147. Gender, cognitive decline, and risk of AD in older persons. Neurology. 2003 Jun 10; 60(11):1777-81.
    View in: PubMed
    Score: 0.092
  148. Neuropathologic correlates of cerebral microbleeds in community-based older adults. Neurobiol Aging. 2023 09; 129:89-98.
    View in: PubMed
    Score: 0.092
  149. Plasma p-tau181 and p-tau217 in discriminating PART, AD and other key neuropathologies in older adults. Acta Neuropathol. 2023 07; 146(1):1-11.
    View in: PubMed
    Score: 0.091
  150. Parkinsonianlike signs and risk of incident Alzheimer disease in older persons. Arch Neurol. 2003 Apr; 60(4):539-44.
    View in: PubMed
    Score: 0.091
  151. Association of Mediterranean-DASH Intervention for Neurodegenerative Delay and Mediterranean Diets With Alzheimer Disease Pathology. Neurology. 2023 05 30; 100(22):e2259-e2268.
    View in: PubMed
    Score: 0.091
  152. Predicting age at Alzheimer's dementia onset with the cognitive clock. Alzheimers Dement. 2023 08; 19(8):3555-3562.
    View in: PubMed
    Score: 0.090
  153. Apolipoprotein E epsilon4 allele, AD pathology, and the clinical expression of Alzheimer's disease. Neurology. 2003 Jan 28; 60(2):246-52.
    View in: PubMed
    Score: 0.090
  154. Multi-omic characterization of brain changes in the vascular endothelial growth factor family during aging and Alzheimer's disease. Neurobiol Aging. 2023 06; 126:25-33.
    View in: PubMed
    Score: 0.090
  155. Association of Stroke and Cerebrovascular Pathologies With Scam Susceptibility in Older Adults. JAMA Neurol. 2023 01 01; 80(1):49-57.
    View in: PubMed
    Score: 0.090
  156. Genome-Wide Mapping Implicates 5-Hydroxymethylcytosines in Diabetes Mellitus and Alzheimer's Disease. J Alzheimers Dis. 2023; 93(3):1135-1151.
    View in: PubMed
    Score: 0.090
  157. Acculturation in Context and Brain Health in Older Latino Adults: A Diffusion Tensor Imaging Study. J Alzheimers Dis. 2023; 95(4):1585-1595.
    View in: PubMed
    Score: 0.090
  158. Well-Being and Cognitive Resilience to Dementia-Related Neuropathology. Psychol Sci. 2023 03; 34(3):283-297.
    View in: PubMed
    Score: 0.089
  159. The apolipoprotein E epsilon 2 allele and decline in episodic memory. J Neurol Neurosurg Psychiatry. 2002 Dec; 73(6):672-7.
    View in: PubMed
    Score: 0.089
  160. The Caribbean-Hispanic Alzheimer's disease brain transcriptome reveals ancestry-specific disease mechanisms. Neurobiol Dis. 2023 01; 176:105938.
    View in: PubMed
    Score: 0.089
  161. Co-expression network analysis of frontal cortex during the progression of Alzheimer's disease. Cereb Cortex. 2022 11 09; 32(22):5108-5120.
    View in: PubMed
    Score: 0.089
  162. Fragmentation of rest periods, astrocyte activation, and cognitive decline in older adults with and without Alzheimer's disease. Alzheimers Dement. 2023 05; 19(5):1888-1900.
    View in: PubMed
    Score: 0.089
  163. Cerebrospinal fluid shunting for Alzheimer's disease? Neurology. 2002 Oct 22; 59(8):1126-7.
    View in: PubMed
    Score: 0.088
  164. Eicosanoid lipidome activation in post-mortem brain tissues of individuals with APOE4 and Alzheimer's dementia. Alzheimers Res Ther. 2022 10 11; 14(1):152.
    View in: PubMed
    Score: 0.088
  165. Brain copper may protect from cognitive decline and Alzheimer's disease pathology: a community-based study. Mol Psychiatry. 2022 10; 27(10):4307-4313.
    View in: PubMed
    Score: 0.088
  166. Multiple gene variants linked to Alzheimer's-type clinical dementia via GWAS are also associated with non-Alzheimer's neuropathologic entities. Neurobiol Dis. 2022 Nov; 174:105880.
    View in: PubMed
    Score: 0.088
  167. Genotype-phenotype correlation of T-cell subtypes reveals senescent and cytotoxic genes in Alzheimer's disease. Hum Mol Genet. 2022 09 29; 31(19):3355-3366.
    View in: PubMed
    Score: 0.088
  168. Cognitive decline and hippocampal functional connectivity within older Black adults. Hum Brain Mapp. 2022 11; 43(16):5044-5052.
    View in: PubMed
    Score: 0.088
  169. Depressive symptoms, cognitive decline, and risk of AD in older persons. Neurology. 2002 Aug 13; 59(3):364-70.
    View in: PubMed
    Score: 0.087
  170. APOE e4 and Alzheimer's disease diagnosis associated differences in L-carnitine, GBB, TMAO, and acylcarnitines in blood and brain. Curr Res Transl Med. 2023 Jan-Mar; 71(1):103362.
    View in: PubMed
    Score: 0.087
  171. Cognitive domain harmonization and cocalibration in studies of older adults. Neuropsychology. 2023 May; 37(4):409-423.
    View in: PubMed
    Score: 0.087
  172. Aging the brain: multi-region methylation principal component based clock in the context of Alzheimer's disease. Aging (Albany NY). 2022 07 30; 14(14):5641-5668.
    View in: PubMed
    Score: 0.087
  173. Sex differences in the genetic architecture of cognitive resilience to Alzheimer's disease. Brain. 2022 07 29; 145(7):2541-2554.
    View in: PubMed
    Score: 0.087
  174. Adherence to MIND Diet, Genetic Susceptibility, and Incident Dementia in Three US Cohorts. Nutrients. 2022 Jul 03; 14(13).
    View in: PubMed
    Score: 0.087
  175. The apolipoprotein E epsilon 4 allele and decline in different cognitive systems during a 6-year period. Arch Neurol. 2002 Jul; 59(7):1154-60.
    View in: PubMed
    Score: 0.087
  176. RNASE6 is a novel modifier of APOE-e4 effects on cognition. Neurobiol Aging. 2022 10; 118:66-76.
    View in: PubMed
    Score: 0.087
  177. Calcium-dependent cytosolic phospholipase A2 activation is implicated in neuroinflammation and oxidative stress associated with ApoE4. Mol Neurodegener. 2022 06 15; 17(1):42.
    View in: PubMed
    Score: 0.086
  178. Identification of Dementia in Recent Medicare Claims Data, Compared With Rigorous Clinical Assessments. J Gerontol A Biol Sci Med Sci. 2022 06 01; 77(6):1272-1278.
    View in: PubMed
    Score: 0.086
  179. Limbic-predominant age-related TDP-43 encephalopathy neuropathological change (LATE-NC) is associated with lower R2 relaxation rate: an ex-vivo MRI and pathology investigation. Neurobiol Aging. 2022 09; 117:128-138.
    View in: PubMed
    Score: 0.086
  180. FMNL2 regulates gliovascular interactions and is associated with vascular risk factors and cerebrovascular pathology in Alzheimer's disease. Acta Neuropathol. 2022 07; 144(1):59-79.
    View in: PubMed
    Score: 0.086
  181. Higher Angiotensin II Type 1 Receptor Levels and Activity in the Postmortem Brains of Older Persons with Alzheimer's Dementia. J Gerontol A Biol Sci Med Sci. 2022 04 01; 77(4):664-672.
    View in: PubMed
    Score: 0.085
  182. Association of Traumatic Brain Injury With and Without Loss of Consciousness With Neuropathologic Outcomes in Community-Dwelling Older Persons. JAMA Netw Open. 2022 04 01; 5(4):e229311.
    View in: PubMed
    Score: 0.085
  183. Caffeine Consumption and Dementia: Are Lewy Bodies the Link? Ann Neurol. 2022 06; 91(6):834-846.
    View in: PubMed
    Score: 0.085
  184. Clinicopathologic Factors Associated With Reversion to Normal Cognition in Patients With Mild Cognitive Impairment. Neurology. 2022 05 17; 98(20):e2036-e2045.
    View in: PubMed
    Score: 0.085
  185. Daytime napping and Alzheimer's dementia: A potential bidirectional relationship. Alzheimers Dement. 2023 01; 19(1):158-168.
    View in: PubMed
    Score: 0.085
  186. Identification of the A?37/42 peptide ratio in CSF as an improved A? biomarker for Alzheimer's disease. Alzheimers Dement. 2023 01; 19(1):79-96.
    View in: PubMed
    Score: 0.085
  187. Cortical Proteins and Individual Differences in Cognitive Resilience in Older Adults. Neurology. 2022 03 29; 98(13):e1304-e1314.
    View in: PubMed
    Score: 0.085
  188. Poor pulmonary function is associated with mild cognitive impairment, its progression to dementia, and brain pathologies: A community-based cohort study. Alzheimers Dement. 2022 12; 18(12):2551-2559.
    View in: PubMed
    Score: 0.084
  189. Participation in cognitively stimulating activities and risk of incident Alzheimer disease. JAMA. 2002 Feb 13; 287(6):742-8.
    View in: PubMed
    Score: 0.084
  190. Blood and brain transcriptome analysis reveals APOE genotype-mediated and immune-related pathways involved in Alzheimer disease. Alzheimers Res Ther. 2022 02 09; 14(1):30.
    View in: PubMed
    Score: 0.084
  191. Protein phosphatase 2A and complement component 4 are linked to the protective effect of APOE ?2 for Alzheimer's disease. Alzheimers Dement. 2022 11; 18(11):2042-2054.
    View in: PubMed
    Score: 0.084
  192. Progranulin mutations in clinical and neuropathological Alzheimer's disease. Alzheimers Dement. 2022 12; 18(12):2458-2467.
    View in: PubMed
    Score: 0.084
  193. Inferring protein expression changes from mRNA in Alzheimer's dementia using deep neural networks. Nat Commun. 2022 02 03; 13(1):655.
    View in: PubMed
    Score: 0.084
  194. Large-scale deep multi-layer analysis of Alzheimer's disease brain reveals strong proteomic disease-related changes not observed at the RNA level. Nat Neurosci. 2022 02; 25(2):213-225.
    View in: PubMed
    Score: 0.084
  195. Quantifying longitudinal cognitive resilience to Alzheimer's disease and other neuropathologies. Alzheimers Dement. 2022 11; 18(11):2252-2261.
    View in: PubMed
    Score: 0.084
  196. Association of small vessel disease with tau pathology. Acta Neuropathol. 2022 03; 143(3):349-362.
    View in: PubMed
    Score: 0.084
  197. The National Institute on Aging Late-Onset Alzheimer's Disease Family Based Study: A resource for genetic discovery. Alzheimers Dement. 2022 10; 18(10):1889-1897.
    View in: PubMed
    Score: 0.084
  198. Improved detection of substantia nigra pathology in Alzheimer's disease. J Histochem Cytochem. 2002 Jan; 50(1):99-106.
    View in: PubMed
    Score: 0.084
  199. Pelargonidin and Berry Intake Association with Alzheimer's Disease Neuropathology: A Community-Based Study. J Alzheimers Dis. 2022; 88(2):653-661.
    View in: PubMed
    Score: 0.084
  200. Risk Models Based on Non-Cognitive Measures May Identify Presymptomatic Alzheimer's Disease. J Alzheimers Dis. 2022; 89(4):1249-1262.
    View in: PubMed
    Score: 0.084
  201. Whole genome sequencing-based copy number variations reveal novel pathways and targets in Alzheimer's disease. Alzheimers Dement. 2022 10; 18(10):1846-1867.
    View in: PubMed
    Score: 0.083
  202. Genetic Evidence Supporting a Causal Role of Depression in Alzheimer's Disease. Biol Psychiatry. 2022 07 01; 92(1):25-33.
    View in: PubMed
    Score: 0.083
  203. Integration of GWAS and brain transcriptomic analyses in a multiethnic sample of 35,245 older adults identifies DCDC2 gene as predictor of episodic memory maintenance. Alzheimers Dement. 2022 10; 18(10):1797-1811.
    View in: PubMed
    Score: 0.083
  204. Atlas of RNA editing events affecting protein expression in aged and Alzheimer's disease human brain tissue. Nat Commun. 2021 12 02; 12(1):7035.
    View in: PubMed
    Score: 0.083
  205. Integrative metabolomics-genomics approach reveals key metabolic pathways and regulators of Alzheimer's disease. Alzheimers Dement. 2022 06; 18(6):1260-1278.
    View in: PubMed
    Score: 0.083
  206. Characterization of mitochondrial DNA quantity and quality in the human aged and Alzheimer's disease brain. Mol Neurodegener. 2021 11 06; 16(1):75.
    View in: PubMed
    Score: 0.083
  207. Role of Retinoid X Receptors (RXRs) and dietary vitamin A in Alzheimer's disease: Evidence from clinicopathological and preclinical studies. Neurobiol Dis. 2021 12; 161:105542.
    View in: PubMed
    Score: 0.083
  208. BMI1 is associated with CS8F amyloid-? and rates of cognitive decline in Alzheimer's disease. Alzheimers Res Ther. 2021 10 05; 13(1):164.
    View in: PubMed
    Score: 0.082
  209. Sex-Specific Association of the X Chromosome With Cognitive Change and Tau Pathology in Aging and Alzheimer Disease. JAMA Neurol. 2021 10 01; 78(10):1249-1254.
    View in: PubMed
    Score: 0.082
  210. The association of Lewy bodies with limbic-predominant age-related TDP-43 encephalopathy neuropathologic changes and their role in cognition and Alzheimer's dementia in older persons. Acta Neuropathol Commun. 2021 09 25; 9(1):156.
    View in: PubMed
    Score: 0.082
  211. In vivo and neuropathology data support locus coeruleus integrity as indicator of Alzheimer's disease pathology and cognitive decline. Sci Transl Med. 2021 Sep 22; 13(612):eabj2511.
    View in: PubMed
    Score: 0.082
  212. Epigenomic features related to microglia are associated with attenuated effect of APOE e4 on Alzheimer's disease risk in humans. Alzheimers Dement. 2022 04; 18(4):688-699.
    View in: PubMed
    Score: 0.082
  213. Integrative brain transcriptome analysis links complement component 4 and HSPA2 to the APOE e2 protective effect in Alzheimer disease. Mol Psychiatry. 2021 10; 26(10):6054-6064.
    View in: PubMed
    Score: 0.082
  214. Stem cell-derived neurons reflect features of protein networks, neuropathology, and cognitive outcome of their aged human donors. Neuron. 2021 11 03; 109(21):3402-3420.e9.
    View in: PubMed
    Score: 0.082
  215. Protein farnesylation is upregulated in Alzheimer's human brains and neuron-specific suppression of farnesyltransferase mitigates pathogenic processes in Alzheimer's model mice. Acta Neuropathol Commun. 2021 07 27; 9(1):129.
    View in: PubMed
    Score: 0.081
  216. ARTS: A novel In-vivo classifier of arteriolosclerosis for the older adult brain. Neuroimage Clin. 2021; 31:102768.
    View in: PubMed
    Score: 0.081
  217. A machine learning approach to brain epigenetic analysis reveals kinases associated with Alzheimer's disease. Nat Commun. 2021 07 22; 12(1):4472.
    View in: PubMed
    Score: 0.081
  218. Cognitive Activity and Onset Age of Incident Alzheimer Disease Dementia. Neurology. 2021 08 31; 97(9):e922-e929.
    View in: PubMed
    Score: 0.081
  219. The association of epigenetic clocks in brain tissue with brain pathologies and common aging phenotypes. Neurobiol Dis. 2021 09; 157:105428.
    View in: PubMed
    Score: 0.081
  220. A meta-analysis of epigenome-wide association studies in Alzheimer's disease highlights novel differentially methylated loci across cortex. Nat Commun. 2021 06 10; 12(1):3517.
    View in: PubMed
    Score: 0.080
  221. Impact of Early Life Socioeconomic Status on Decision Making in Older Adults Without Dementia. Arch Gerontol Geriatr. 2021 Jul-Aug; 95:104432.
    View in: PubMed
    Score: 0.080
  222. Neuronal ApoE upregulates MHC-I expression to drive selective neurodegeneration in Alzheimer's disease. Nat Neurosci. 2021 06; 24(6):786-798.
    View in: PubMed
    Score: 0.080
  223. Sarcopenia is associated with incident Alzheimer's dementia, mild cognitive impairment, and cognitive decline. J Am Geriatr Soc. 2021 07; 69(7):1826-1835.
    View in: PubMed
    Score: 0.080
  224. Public health importance of vascular dementia and Alzheimer's disease with cerebrovascular disease. Int J Clin Pract Suppl. 2001 May; (120):41-8.
    View in: PubMed
    Score: 0.080
  225. Synaptic proteins associated with cognitive performance and neuropathology in older humans revealed by multiplexed fractionated proteomics. Neurobiol Aging. 2021 09; 105:99-114.
    View in: PubMed
    Score: 0.080
  226. PLD3 is a neuronal lysosomal phospholipase D associated with ?-amyloid plaques and cognitive function in Alzheimer's disease. PLoS Genet. 2021 04; 17(4):e1009406.
    View in: PubMed
    Score: 0.079
  227. Novel Variance-Component TWAS method for studying complex human diseases with applications to Alzheimer's dementia. PLoS Genet. 2021 04; 17(4):e1009482.
    View in: PubMed
    Score: 0.079
  228. Acculturation in Context: The Relationship Between Acculturation and Socioenvironmental Factors With Level of and Change in Cognition in Older Latinos. J Gerontol B Psychol Sci Soc Sci. 2021 03 14; 76(4):e129-e139.
    View in: PubMed
    Score: 0.079
  229. Systemic brain derived neurotrophic factor but not intestinal barrier integrity is associated with cognitive decline and incident Alzheimer's disease. PLoS One. 2021; 16(3):e0240342.
    View in: PubMed
    Score: 0.079
  230. Genome-wide epistasis analysis for Alzheimer's disease and implications for genetic risk prediction. Alzheimers Res Ther. 2021 03 04; 13(1):55.
    View in: PubMed
    Score: 0.079
  231. Exome-wide age-of-onset analysis reveals exonic variants in ERN1 and SPPL2C associated with Alzheimer's disease. Transl Psychiatry. 2021 02 26; 11(1):146.
    View in: PubMed
    Score: 0.079
  232. Neuroticism alters the transcriptome of the frontal cortex to contribute to the cognitive decline and onset of Alzheimer's disease. Transl Psychiatry. 2021 02 24; 11(1):139.
    View in: PubMed
    Score: 0.079
  233. Brain DNA Methylation Patterns in CLDN5 Associated With Cognitive Decline. Biol Psychiatry. 2022 02 15; 91(4):389-398.
    View in: PubMed
    Score: 0.078
  234. Integrating human brain proteomes with genome-wide association data implicates new proteins in Alzheimer's disease pathogenesis. Nat Genet. 2021 02; 53(2):143-146.
    View in: PubMed
    Score: 0.078
  235. A cortical immune network map identifies distinct microglial transcriptional programs associated with ?-amyloid and Tau pathologies. Transl Psychiatry. 2021 01 14; 11(1):50.
    View in: PubMed
    Score: 0.078
  236. Novel Alzheimer Disease Risk Loci and Pathways in African American Individuals Using the African Genome Resources Panel: A Meta-analysis. JAMA Neurol. 2021 01 01; 78(1):102-113.
    View in: PubMed
    Score: 0.078
  237. MIND Diet, Common Brain Pathologies, and Cognition in Community-Dwelling Older Adults. J Alzheimers Dis. 2021; 83(2):683-692.
    View in: PubMed
    Score: 0.078
  238. Cerebral small vessel disease genomics and its implications across the lifespan. Nat Commun. 2020 12 08; 11(1):6285.
    View in: PubMed
    Score: 0.078
  239. EPIGENOMIC FEATURES RELATED TO MICROGLIA ARE ASSOCIATED WITH ATTENUATED EFFECT OF APOE e4 ON ALZHEIMER'S DISEASE RISK IN HUMANS. Alzheimers Dement. 2020 12; 16(Suppl 2).
    View in: PubMed
    Score: 0.078
  240. Single cell RNA sequencing of human microglia uncovers a subset associated with Alzheimer's disease. Nat Commun. 2020 11 30; 11(1):6129.
    View in: PubMed
    Score: 0.078
  241. Circadian disturbances in Alzheimer's disease progression: a prospective observational cohort study of community-based older adults. Lancet Healthy Longev. 2020 12; 1(3):e96-e105.
    View in: PubMed
    Score: 0.077
  242. Association of serial position scores on memory tests and hippocampal-related neuropathologic outcomes. Neurology. 2020 12 15; 95(24):e3303-e3312.
    View in: PubMed
    Score: 0.077
  243. A new role for matrix metalloproteinase-3 in the NGF metabolic pathway: Proteolysis of mature NGF and sex-specific differences in the continuum of Alzheimer's pathology. Neurobiol Dis. 2021 01; 148:105150.
    View in: PubMed
    Score: 0.077
  244. Part I. Epidemiology and public health impact of Alzheimer's disease. Dis Mon. 2000 Oct; 46(10):657-65.
    View in: PubMed
    Score: 0.077
  245. Part II. Clinical diagnosis and course of Alzheimer's disease. Dis Mon. 2000 Oct; 46(10):666-86.
    View in: PubMed
    Score: 0.077
  246. Association Between Common Variants in RBFOX1, an RNA-Binding Protein, and Brain Amyloidosis in Early and Preclinical Alzheimer Disease. JAMA Neurol. 2020 10 01; 77(10):1288-1298.
    View in: PubMed
    Score: 0.077
  247. Bayesian Genome-wide TWAS Method to Leverage both cis- and trans-eQTL Information through Summary Statistics. Am J Hum Genet. 2020 10 01; 107(4):714-726.
    View in: PubMed
    Score: 0.076
  248. Cross-Species Analyses Identify Dlgap2 as a Regulator of Age-Related Cognitive Decline and Alzheimer's Dementia. Cell Rep. 2020 09 01; 32(9):108091.
    View in: PubMed
    Score: 0.076
  249. A second X chromosome contributes to resilience in a mouse model of Alzheimer's disease. Sci Transl Med. 2020 08 26; 12(558).
    View in: PubMed
    Score: 0.076
  250. Limbic-predominant age-related TDP-43 encephalopathy in Black and White decedents. Neurology. 2020 10 13; 95(15):e2056-e2064.
    View in: PubMed
    Score: 0.076
  251. Limbic-predominant age-related TDP-43 encephalopathy, ADNC pathology, and cognitive decline in aging. Neurology. 2020 10 06; 95(14):e1951-e1962.
    View in: PubMed
    Score: 0.076
  252. Genetic variants and functional pathways associated with resilience to Alzheimer's disease. Brain. 2020 08 01; 143(8):2561-2575.
    View in: PubMed
    Score: 0.076
  253. Brain Insulin Signaling, Alzheimer Disease Pathology, and Cognitive Function. Ann Neurol. 2020 09; 88(3):513-525.
    View in: PubMed
    Score: 0.076
  254. Meta-Analysis of the Alzheimer's Disease Human Brain Transcriptome and Functional Dissection in Mouse Models. Cell Rep. 2020 07 14; 32(2):107908.
    View in: PubMed
    Score: 0.075
  255. Sex-dependent autosomal effects on clinical progression of Alzheimer's disease. Brain. 2020 07 01; 143(7):2272-2280.
    View in: PubMed
    Score: 0.075
  256. Genome-wide association study of rate of cognitive decline in Alzheimer's disease patients identifies novel genes and pathways. Alzheimers Dement. 2020 08; 16(8):1134-1145.
    View in: PubMed
    Score: 0.075
  257. Healthy lifestyle and the risk of Alzheimer dementia: Findings from 2 longitudinal studies. Neurology. 2020 07 28; 95(4):e374-e383.
    View in: PubMed
    Score: 0.075
  258. The human brain NGF metabolic pathway is impaired in the pre-clinical and clinical continuum of Alzheimers disease. Mol Psychiatry. 2021 10; 26(10):6023-6037.
    View in: PubMed
    Score: 0.075
  259. From healthy aging to early Alzheimer's disease: in vivo detection of entorhinal cortex atrophy. Ann N Y Acad Sci. 2000 Jun; 911:240-53.
    View in: PubMed
    Score: 0.075
  260. Shared proteomic effects of cerebral atherosclerosis and Alzheimer's disease on the human brain. Nat Neurosci. 2020 06; 23(6):696-700.
    View in: PubMed
    Score: 0.075
  261. Genome-wide interaction analysis of pathological hallmarks in Alzheimer's disease. Neurobiol Aging. 2020 09; 93:61-68.
    View in: PubMed
    Score: 0.074
  262. Large-scale proteomic analysis of Alzheimer's disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation. Nat Med. 2020 05; 26(5):769-780.
    View in: PubMed
    Score: 0.074
  263. Bayesian integrative analysis of epigenomic and transcriptomic data identifies Alzheimer's disease candidate genes and networks. PLoS Comput Biol. 2020 04; 16(4):e1007771.
    View in: PubMed
    Score: 0.074
  264. Shared Causal Paths underlying Alzheimer's dementia and Type 2 Diabetes. Sci Rep. 2020 03 05; 10(1):4107.
    View in: PubMed
    Score: 0.074
  265. Sex and APOE e4 genotype modify the Alzheimer's disease serum metabolome. Nat Commun. 2020 03 02; 11(1):1148.
    View in: PubMed
    Score: 0.074
  266. Variability and Coupling of Olfactory Identification and Episodic Memory in Older Adults. J Gerontol B Psychol Sci Soc Sci. 2020 02 14; 75(3):577-584.
    View in: PubMed
    Score: 0.073
  267. Brain mural cell loss in the parietal cortex in Alzheimer's disease correlates with cognitive decline and TDP-43 pathology. Neuropathol Appl Neurobiol. 2020 08; 46(5):458-477.
    View in: PubMed
    Score: 0.073
  268. Exceptionally low likelihood of Alzheimer's dementia in APOE2 homozygotes from a 5,000-person neuropathological study. Nat Commun. 2020 02 03; 11(1):667.
    View in: PubMed
    Score: 0.073
  269. Dietary flavonols and risk of Alzheimer dementia. Neurology. 2020 04 21; 94(16):e1749-e1756.
    View in: PubMed
    Score: 0.073
  270. Human Herpesvirus 6 Detection in Alzheimer's Disease Cases and Controls across Multiple Cohorts. Neuron. 2020 03 18; 105(6):1027-1035.e2.
    View in: PubMed
    Score: 0.073
  271. Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer's disease. Nat Med. 2020 01; 26(1):131-142.
    View in: PubMed
    Score: 0.073
  272. Hemispheric differences in hippocampal volume predict verbal and spatial memory performance in patients with Alzheimer's disease. Hippocampus. 2000; 10(2):136-42.
    View in: PubMed
    Score: 0.073
  273. A Latent Transition Analysis Model to Assess Change in Cognitive States over Three Occasions: Results from the Rush Memory and Aging Project. J Alzheimers Dis. 2020; 73(3):1063-1073.
    View in: PubMed
    Score: 0.073
  274. Confidence in Financial and Health Literacy and Cognitive Health in Older Persons J Alzheimers Dis. 2020; 75(4):1229-1240.
    View in: PubMed
    Score: 0.073
  275. Association of Low Systolic Blood Pressure with Postmortem Amyloid-? and Tau. J Alzheimers Dis. 2020; 78(4):1755-1764.
    View in: PubMed
    Score: 0.073
  276. Association of Strawberries and Anthocyanidin Intake with Alzheimer's Dementia Risk. Nutrients. 2019 Dec 14; 11(12).
    View in: PubMed
    Score: 0.073
  277. Sleep fragmentation, microglial aging, and cognitive impairment in adults with and without Alzheimer's dementia. Sci Adv. 2019 12; 5(12):eaax7331.
    View in: PubMed
    Score: 0.072
  278. Contribution of TDP and hippocampal sclerosis to hippocampal volume loss in older-old persons. Neurology. 2020 01 14; 94(2):e142-e152.
    View in: PubMed
    Score: 0.072
  279. Brain and blood metabolome for Alzheimer's dementia: findings from a targeted metabolomics analysis. Neurobiol Aging. 2020 02; 86:123-133.
    View in: PubMed
    Score: 0.072
  280. Hospitalization, Alzheimer's Disease and Related Neuropathologies, and Cognitive Decline. Ann Neurol. 2019 12; 86(6):844-852.
    View in: PubMed
    Score: 0.072
  281. Diagnosis and Management of Dementia: Review. JAMA. 2019 10 22; 322(16):1589-1599.
    View in: PubMed
    Score: 0.072
  282. Tau-Mediated Disruption of the Spliceosome Triggers Cryptic RNA Splicing and Neurodegeneration in Alzheimer's Disease. Cell Rep. 2019 10 08; 29(2):301-316.e10.
    View in: PubMed
    Score: 0.072
  283. 3D mapping reveals network-specific amyloid progression and subcortical susceptibility in mice. Commun Biol. 2019; 2:360.
    View in: PubMed
    Score: 0.072
  284. Association of TDP-43 Pathology With Domain-specific Literacy in Older Persons. Alzheimer Dis Assoc Disord. 2019 Oct-Dec; 33(4):315-320.
    View in: PubMed
    Score: 0.071
  285. Sex differences in the genetic predictors of Alzheimer's pathology. Brain. 2019 09 01; 142(9):2581-2589.
    View in: PubMed
    Score: 0.071
  286. Interaction between the progression of Alzheimer's disease and fractal degradation. Neurobiol Aging. 2019 11; 83:21-30.
    View in: PubMed
    Score: 0.071
  287. cindr, the Drosophila Homolog of the CD2AP Alzheimer's Disease Risk Gene, Is Required for Synaptic Transmission and Proteostasis. Cell Rep. 2019 08 13; 28(7):1799-1813.e5.
    View in: PubMed
    Score: 0.071
  288. Gene expression and DNA methylation are extensively coordinated with MRI-based brain microstructural characteristics. Brain Imaging Behav. 2019 Aug; 13(4):963-972.
    View in: PubMed
    Score: 0.071
  289. Integrating Gene and Protein Expression Reveals Perturbed Functional Networks in Alzheimer's Disease. Cell Rep. 2019 07 23; 28(4):1103-1116.e4.
    View in: PubMed
    Score: 0.071
  290. Brain expression of the vascular endothelial growth factor gene family in cognitive aging and alzheimer's disease. Mol Psychiatry. 2021 03; 26(3):888-896.
    View in: PubMed
    Score: 0.071
  291. Association of Cortical ?-Amyloid Protein in the Absence of Insoluble Deposits With Alzheimer Disease. JAMA Neurol. 2019 07 01; 76(7):818-826.
    View in: PubMed
    Score: 0.070
  292. CpG-related SNPs in the MS4A region have a dose-dependent effect on risk of late-onset Alzheimer disease. Aging Cell. 2019 08; 18(4):e12964.
    View in: PubMed
    Score: 0.070
  293. Rate of brain aging and APOE e4 are synergistic risk factors for Alzheimer's disease. Life Sci Alliance. 2019 06; 2(3).
    View in: PubMed
    Score: 0.070
  294. Human Hippocampal Neurogenesis Persists in Aged Adults and Alzheimer's Disease Patients. Cell Stem Cell. 2019 06 06; 24(6):974-982.e3.
    View in: PubMed
    Score: 0.070
  295. Single-cell transcriptomic analysis of Alzheimer's disease. Nature. 2019 06; 570(7761):332-337.
    View in: PubMed
    Score: 0.069
  296. Dimensionality of parkinsonian signs in aging and Alzheimer's disease. J Gerontol A Biol Sci Med Sci. 1999 Apr; 54(4):M191-6.
    View in: PubMed
    Score: 0.069
  297. Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates A?, tau, immunity and lipid processing. Nat Genet. 2019 03; 51(3):414-430.
    View in: PubMed
    Score: 0.069
  298. Risk Aversion and Alzheimer Disease in Old Age. Am J Geriatr Psychiatry. 2019 08; 27(8):851-861.
    View in: PubMed
    Score: 0.069
  299. Hippocampal gene expression patterns linked to late-life physical activity oppose age and AD-related transcriptional decline. Neurobiol Aging. 2019 06; 78:142-154.
    View in: PubMed
    Score: 0.069
  300. Beta-amyloid pathology in human brain microvessel extracts from the parietal cortex: relation with cerebral amyloid angiopathy and Alzheimer's disease. Acta Neuropathol. 2019 05; 137(5):801-823.
    View in: PubMed
    Score: 0.068
  301. Investigation of frailty as a moderator of the relationship between neuropathology and dementia in Alzheimer's disease: a cross-sectional analysis of data from the Rush Memory and Aging Project. Lancet Neurol. 2019 02; 18(2):177-184.
    View in: PubMed
    Score: 0.068
  302. Polygenic hazard score, amyloid deposition and Alzheimer's neurodegeneration. Brain. 2019 02 01; 142(2):460-470.
    View in: PubMed
    Score: 0.068
  303. "Alzheimer's disease" is neither "Alzheimer's clinical syndrome" nor "dementia". Alzheimers Dement. 2019 01; 15(1):153-157.
    View in: PubMed
    Score: 0.068
  304. Associations Between Depression, Traumatic Brain Injury, and Cognitively-Defined Late-Onset Alzheimer's Disease Subgroups. J Alzheimers Dis. 2019; 70(2):611-619.
    View in: PubMed
    Score: 0.068
  305. DNA methylation variability in Alzheimer's disease. Neurobiol Aging. 2019 04; 76:35-44.
    View in: PubMed
    Score: 0.068
  306. Epigenome-wide study uncovers large-scale changes in histone acetylation driven by tau pathology in aging and Alzheimer's human brains. Nat Neurosci. 2019 01; 22(1):37-46.
    View in: PubMed
    Score: 0.068
  307. Genetic data and cognitively defined late-onset Alzheimer's disease subgroups. Mol Psychiatry. 2020 11; 25(11):2942-2951.
    View in: PubMed
    Score: 0.068
  308. Episodic memory performance in a multi-ethnic longitudinal study of 13,037 elderly. PLoS One. 2018; 13(11):e0206803.
    View in: PubMed
    Score: 0.067
  309. Dissecting the genetic relationship between cardiovascular risk factors and Alzheimer's disease. Acta Neuropathol. 2019 02; 137(2):209-226.
    View in: PubMed
    Score: 0.067
  310. In vivo hippocampal subfield shape related to TDP-43, amyloid beta, and tau pathologies. Neurobiol Aging. 2019 02; 74:171-181.
    View in: PubMed
    Score: 0.067
  311. Altered bile acid profile associates with cognitive impairment in Alzheimer's disease-An emerging role for gut microbiome. Alzheimers Dement. 2019 01; 15(1):76-92.
    View in: PubMed
    Score: 0.067
  312. APOE genotypes as a risk factor for age-dependent accumulation of cerebrovascular disease in older adults. Alzheimers Dement. 2019 02; 15(2):258-266.
    View in: PubMed
    Score: 0.067
  313. Integrative transcriptome analyses of the aging brain implicate altered splicing in Alzheimer's disease susceptibility. Nat Genet. 2018 11; 50(11):1584-1592.
    View in: PubMed
    Score: 0.067
  314. Seasonal plasticity of cognition and related biological measures in adults with and without Alzheimer disease: Analysis of multiple cohorts. PLoS Med. 2018 09; 15(9):e1002647.
    View in: PubMed
    Score: 0.066
  315. Isoform-specific hyperactivation of calpain-2 occurs presymptomatically at the synapse in Alzheimer's disease mice and correlates with memory deficits in human subjects. Sci Rep. 2018 09 03; 8(1):13119.
    View in: PubMed
    Score: 0.066
  316. The human brainome: network analysis identifies HSPA2 as a novel Alzheimer’s disease target. Brain. 2018 09 01; 141(9):2721-2739.
    View in: PubMed
    Score: 0.066
  317. Object decision priming in Alzheimer's disease. J Int Neuropsychol Soc. 1998 Sep; 4(5):435-46.
    View in: PubMed
    Score: 0.066
  318. Sex-Specific Association of Apolipoprotein E With Cerebrospinal Fluid Levels of Tau. JAMA Neurol. 2018 08 01; 75(8):989-998.
    View in: PubMed
    Score: 0.066
  319. Late-life blood pressure association with cerebrovascular and Alzheimer disease pathology. Neurology. 2018 08 07; 91(6):e517-e525.
    View in: PubMed
    Score: 0.066
  320. Selective disruption of TLR2-MyD88 interaction inhibits inflammation and attenuates Alzheimer's pathology. J Clin Invest. 2018 10 01; 128(10):4297-4312.
    View in: PubMed
    Score: 0.066
  321. Sex-specific genetic predictors of Alzheimer's disease biomarkers. Acta Neuropathol. 2018 12; 136(6):857-872.
    View in: PubMed
    Score: 0.066
  322. Tau Activates Transposable Elements in Alzheimer's Disease. Cell Rep. 2018 06 05; 23(10):2874-2880.
    View in: PubMed
    Score: 0.065
  323. Parkinsonian signs and mortality from Alzheimer's disease. Lancet. 1998 May 30; 351(9116):1631.
    View in: PubMed
    Score: 0.065
  324. A molecular network of the aging human brain provides insights into the pathology and cognitive decline of Alzheimer's disease. Nat Neurosci. 2018 06; 21(6):811-819.
    View in: PubMed
    Score: 0.065
  325. Fractal regulation and incident Alzheimer's disease in elderly individuals. Alzheimers Dement. 2018 09; 14(9):1114-1125.
    View in: PubMed
    Score: 0.065
  326. Fish Intake, Genetic Predisposition to Alzheimer Disease, and Decline in Global Cognition and Memory in 5 Cohorts of Older Persons. Am J Epidemiol. 2018 05 01; 187(5):933-940.
    View in: PubMed
    Score: 0.065
  327. A Common DIO2 Polymorphism and Alzheimer Disease Dementia in African and European Americans. J Clin Endocrinol Metab. 2018 05 01; 103(5):1818-1826.
    View in: PubMed
    Score: 0.065
  328. TDP-43 pathology in anterior temporal pole cortex in aging and Alzheimer's disease. Acta Neuropathol Commun. 2018 05 01; 6(1):33.
    View in: PubMed
    Score: 0.065
  329. Sexual dimorphism in predisposition to Alzheimer's disease. Neurobiol Aging. 2018 10; 70:308-324.
    View in: PubMed
    Score: 0.065
  330. NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease. Alzheimers Dement. 2018 04; 14(4):535-562.
    View in: PubMed
    Score: 0.064
  331. Integrated biology approach reveals molecular and pathological interactions among Alzheimer's A?42, Tau, TREM2, and TYROBP in Drosophila models. Genome Med. 2018 03 29; 10(1):26.
    View in: PubMed
    Score: 0.064
  332. Elevated DNA methylation across a 48-kb region spanning the HOXA gene cluster is associated with Alzheimer's disease neuropathology. Alzheimers Dement. 2018 12; 14(12):1580-1588.
    View in: PubMed
    Score: 0.064
  333. A Bayesian Framework for Generalized Linear Mixed Modeling Identifies New Candidate Loci for Late-Onset Alzheimer's Disease. Genetics. 2018 05; 209(1):51-64.
    View in: PubMed
    Score: 0.064
  334. A transcriptomic atlas of aged human microglia. Nat Commun. 2018 02 07; 9(1):539.
    View in: PubMed
    Score: 0.064
  335. Person-specific contribution of neuropathologies to cognitive loss in old age. Ann Neurol. 2018 01; 83(1):74-83.
    View in: PubMed
    Score: 0.063
  336. Loneliness 5 years ante-mortem is associated with disease-related differential gene expression in postmortem dorsolateral prefrontal cortex. Transl Psychiatry. 2018 01 10; 8(1):2.
    View in: PubMed
    Score: 0.063
  337. Cognitive Aging in Black and White Americans: Cognition, Cognitive Decline, and Incidence of Alzheimer Disease Dementia. Epidemiology. 2018 01; 29(1):151-159.
    View in: PubMed
    Score: 0.063
  338. Longitudinal Modeling of Functional Decline Associated with Pathologic Alzheimer's Disease in Older Persons without Cognitive Impairment. J Alzheimers Dis. 2018; 62(2):855-865.
    View in: PubMed
    Score: 0.063
  339. Class-Specific Incidence of All-Cause Dementia and Alzheimer's Disease: A Latent Class Approach. J Alzheimers Dis. 2018; 66(1):347-357.
    View in: PubMed
    Score: 0.063
  340. A? mediates F-actin disassembly in dendritic spines leading to cognitive deficits in Alzheimer's disease. J Neurosci. 2018 01 31; 38(5):1085-1099.
    View in: PubMed
    Score: 0.063
  341. Polygenic hazard score: an enrichment marker for Alzheimer's associated amyloid and tau deposition. Acta Neuropathol. 2018 01; 135(1):85-93.
    View in: PubMed
    Score: 0.063
  342. Cell-type Dependent Alzheimer's Disease Phenotypes: Probing the Biology of?Selective Neuronal Vulnerability. Stem Cell Reports. 2017 12 12; 9(6):1868-1884.
    View in: PubMed
    Score: 0.063
  343. Alzheimer's Disease-Related Dementias Summit 2016: National research priorities. Neurology. 2017 Dec 05; 89(23):2381-2391.
    View in: PubMed
    Score: 0.063
  344. Genetic influence of plasma homocysteine on Alzheimer's disease. Neurobiol Aging. 2018 02; 62:243.e7-243.e14.
    View in: PubMed
    Score: 0.062
  345. Traumatic brain injury may not increase the risk of Alzheimer disease. Neurology. 2017 Oct 31; 89(18):1923-1925.
    View in: PubMed
    Score: 0.062
  346. Neuronal-expressed microRNA-targeted pseudogenes compete with coding genes in the human brain. Transl Psychiatry. 2017 08 08; 7(8):e1199.
    View in: PubMed
    Score: 0.062
  347. Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease. Nat Genet. 2017 09; 49(9):1373-1384.
    View in: PubMed
    Score: 0.061
  348. Dissecting the role of non-coding RNAs in the accumulation of amyloid and tau neuropathologies in Alzheimer's disease. Mol Neurodegener. 2017 07 01; 12(1):51.
    View in: PubMed
    Score: 0.061
  349. Decline in Literacy and Incident AD Dementia Among Community-Dwelling Older Persons. J Aging Health. 2018 10; 30(9):1389-1405.
    View in: PubMed
    Score: 0.061
  350. Alzheimer's brains show inter-related changes in RNA and lipid metabolism. Neurobiol Dis. 2017 Oct; 106:1-13.
    View in: PubMed
    Score: 0.061
  351. Reactive Oxygen Species-Mediated Loss of Synaptic Akt1 Signaling Leads to Deficient Activity-Dependent Protein Translation Early in Alzheimer's Disease. Antioxid Redox Signal. 2017 Dec 01; 27(16):1269-1280.
    View in: PubMed
    Score: 0.060
  352. Diurnal and seasonal molecular rhythms in human neocortex and their relation to Alzheimer's disease. Nat Commun. 2017 04 03; 8:14931.
    View in: PubMed
    Score: 0.060
  353. Genetic epistasis regulates amyloid deposition in resilient aging. Alzheimers Dement. 2017 Oct; 13(10):1107-1116.
    View in: PubMed
    Score: 0.060
  354. Entorhinal Cortex: Antemortem Cortical Thickness and Postmortem Neurofibrillary Tangles and Amyloid Pathology. AJNR Am J Neuroradiol. 2017 May; 38(5):961-965.
    View in: PubMed
    Score: 0.060
  355. Polygenic risk scores in familial Alzheimer disease. Neurology. 2017 Mar 21; 88(12):1180-1186.
    View in: PubMed
    Score: 0.060
  356. Transethnic genome-wide scan identifies novel Alzheimer's disease loci. Alzheimers Dement. 2017 Jul; 13(7):727-738.
    View in: PubMed
    Score: 0.060
  357. Association of Neuropathological Markers in the Parietal Cortex With Antemortem Cognitive Function in Persons With Mild Cognitive Impairment and Alzheimer Disease. J Neuropathol Exp Neurol. 2017 Feb 01; 76(2):70-88.
    View in: PubMed
    Score: 0.059
  358. Diabetes, Hemoglobin A1C, and Regional Alzheimer Disease and Infarct Pathology. Alzheimer Dis Assoc Disord. 2017 Jan-Mar; 31(1):41-47.
    View in: PubMed
    Score: 0.059
  359. Effect Size Analyses of Souvenaid in Patients with Alzheimer's Disease. J Alzheimers Dis. 2017; 55(3):1131-1139.
    View in: PubMed
    Score: 0.059
  360. Association of Cancer History with Alzheimer's Disease Dementia and Neuropathology. J Alzheimers Dis. 2017; 56(2):699-706.
    View in: PubMed
    Score: 0.059
  361. Financial and Health Literacy Predict Incident Alzheimer's Disease Dementia and Pathology. J Alzheimers Dis. 2017; 56(4):1485-1493.
    View in: PubMed
    Score: 0.059
  362. Risk of incident clinical diagnosis of Alzheimer's disease-type dementia?attributable to pathology-confirmed vascular disease. Alzheimers Dement. 2017 Jun; 13(6):613-623.
    View in: PubMed
    Score: 0.059
  363. Increased Caspase-6 activity in the human anterior olfactory nuclei of the olfactory bulb is associated with cognitive impairment. Acta Neuropathol Commun. 2016 12 08; 4(1):127.
    View in: PubMed
    Score: 0.059
  364. A candidate regulatory variant at the TREM gene cluster associates with decreased Alzheimer's disease risk and increased TREML1 and TREM2 brain gene expression. Alzheimers Dement. 2017 Jun; 13(6):663-673.
    View in: PubMed
    Score: 0.059
  365. Circadian alterations during early stages of Alzheimer's disease are associated with aberrant cycles of DNA methylation in BMAL1. Alzheimers Dement. 2017 Jun; 13(6):689-700.
    View in: PubMed
    Score: 0.059
  366. Presynaptic proteins complexin-I and complexin-II differentially influence cognitive function in early and late stages of Alzheimer's disease. Acta Neuropathol. 2017 03; 133(3):395-407.
    View in: PubMed
    Score: 0.059
  367. TDP-43 stage, mixed pathologies, and clinical Alzheimer's-type dementia. Brain. 2016 11 01; 139(11):2983-2993.
    View in: PubMed
    Score: 0.058
  368. Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans. Alzheimers Dement. 2017 02; 13(2):119-129.
    View in: PubMed
    Score: 0.058
  369. The Role of Cardiovascular Risk Factors and Stroke in Familial Alzheimer Disease. JAMA Neurol. 2016 Oct 01; 73(10):1231-1237.
    View in: PubMed
    Score: 0.058
  370. Soluble Conformers of A? and Tau Alter Selective Proteins Governing Axonal Transport. J Neurosci. 2016 09 14; 36(37):9647-58.
    View in: PubMed
    Score: 0.058
  371. Late-life Cognitive Activity and Dementia: A Systematic Review and Bias Analysis. Epidemiology. 2016 09; 27(5):732-42.
    View in: PubMed
    Score: 0.058
  372. The epigenome in Alzheimer's disease: current state and approaches for a new path to gene discovery and understanding disease mechanism. Acta Neuropathol. 2016 10; 132(4):503-14.
    View in: PubMed
    Score: 0.058
  373. Reduced pCREB in Alzheimer's disease prefrontal cortex is reflected in peripheral blood mononuclear cells. Mol Psychiatry. 2016 09; 21(9):1158-66.
    View in: PubMed
    Score: 0.057
  374. A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers. Neurology. 2016 Aug 02; 87(5):539-47.
    View in: PubMed
    Score: 0.057
  375. Evaluation of a Genetic Risk Score to Improve Risk Prediction for Alzheimer's Disease. J Alzheimers Dis. 2016 06 18; 53(3):921-32.
    View in: PubMed
    Score: 0.057
  376. Relation of cerebral vessel disease to Alzheimer's disease dementia and cognitive function in elderly people: a cross-sectional study. Lancet Neurol. 2016 08; 15(9):934-943.
    View in: PubMed
    Score: 0.057
  377. NMNAT2:HSP90 Complex Mediates Proteostasis in Proteinopathies. PLoS Biol. 2016 06; 14(6):e1002472.
    View in: PubMed
    Score: 0.057
  378. Crowdsourced estimation of cognitive decline and resilience in Alzheimer's disease. Alzheimers Dement. 2016 06; 12(6):645-53.
    View in: PubMed
    Score: 0.056
  379. Therapeutic correction of ApoER2 splicing in Alzheimer's disease mice using antisense?oligonucleotides. EMBO Mol Med. 2016 04 01; 8(4):328-45.
    View in: PubMed
    Score: 0.056
  380. Genome-wide interaction study of brain beta-amyloid burden and cognitive impairment in Alzheimer's disease. Mol Psychiatry. 2017 02; 22(2):287-295.
    View in: PubMed
    Score: 0.056
  381. Association of Seafood Consumption, Brain Mercury Level, and APOE e4 Status With Brain Neuropathology in Older Adults. JAMA. 2016 Feb 02; 315(5):489-97.
    View in: PubMed
    Score: 0.055
  382. Diabetes is associated with cerebrovascular but not Alzheimer's disease neuropathology. Alzheimers Dement. 2016 08; 12(8):882-9.
    View in: PubMed
    Score: 0.055
  383. Epigenetic age of the pre-frontal cortex is associated with neuritic plaques, amyloid load, and Alzheimer's disease related cognitive functioning. Aging (Albany NY). 2015 Dec; 7(12):1198-211.
    View in: PubMed
    Score: 0.055
  384. Cerebral amyloid angiopathy and cognitive outcomes in community-based older persons. Neurology. 2015 Dec 01; 85(22):1930-6.
    View in: PubMed
    Score: 0.055
  385. Association of Long Runs of Homozygosity With Alzheimer Disease Among African American Individuals. JAMA Neurol. 2015 Nov; 72(11):1313-23.
    View in: PubMed
    Score: 0.055
  386. Plasma Exosomal miRNAs in Persons with and without Alzheimer Disease: Altered Expression and Prospects for Biomarkers. PLoS One. 2015; 10(10):e0139233.
    View in: PubMed
    Score: 0.054
  387. CD33 modulates TREM2: convergence of Alzheimer loci. Nat Neurosci. 2015 Nov; 18(11):1556-8.
    View in: PubMed
    Score: 0.054
  388. Association of APOE with tau-tangle pathology with and without ?-amyloid. Neurobiol Aging. 2016 Jan; 37:19-25.
    View in: PubMed
    Score: 0.054
  389. Tissue Transglutaminase and Its Product Isopeptide Are Increased in Alzheimer's Disease and APPswe/PS1dE9 Double Transgenic Mice Brains. Mol Neurobiol. 2016 10; 53(8):5066-78.
    View in: PubMed
    Score: 0.054
  390. Genetic variants associated with susceptibility to psychosis in?late-onset Alzheimer's disease families. Neurobiol Aging. 2015 Nov; 36(11):3116.e9-3116.e16.
    View in: PubMed
    Score: 0.054
  391. GWAS of longitudinal amyloid accumulation on 18F-florbetapir PET in Alzheimer's disease implicates microglial activation gene IL1RAP. Brain. 2015 Oct; 138(Pt 10):3076-88.
    View in: PubMed
    Score: 0.054
  392. Effects of Souvenaid on plasma micronutrient levels and fatty acid profiles in mild and mild-to-moderate Alzheimer's disease. Alzheimers Res Ther. 2015; 7(1):51.
    View in: PubMed
    Score: 0.053
  393. GSK3? Interactions with Amyloid Genes: An Autopsy Verification and Extension. Neurotox Res. 2015 Oct; 28(3):232-8.
    View in: PubMed
    Score: 0.053
  394. Mixed pathology is more likely in black than white decedents with Alzheimer dementia. Neurology. 2015 Aug 11; 85(6):528-34.
    View in: PubMed
    Score: 0.053
  395. Suprachiasmatic neuron numbers and rest-activity circadian rhythms in older humans. Ann Neurol. 2015 Aug; 78(2):317-22.
    View in: PubMed
    Score: 0.053
  396. Global and local ancestry in African-Americans: Implications for Alzheimer's disease risk. Alzheimers Dement. 2016 Mar; 12(3):233-43.
    View in: PubMed
    Score: 0.053
  397. Genetically predicted body mass index and Alzheimer's disease-related phenotypes in three large samples: Mendelian randomization analyses. Alzheimers Dement. 2015 Dec; 11(12):1439-1451.
    View in: PubMed
    Score: 0.053
  398. Hippocampal sclerosis and TDP-43 pathology in aging and Alzheimer disease. Ann Neurol. 2015 Jun; 77(6):942-52.
    View in: PubMed
    Score: 0.053
  399. Effect of common neuropathologies on progression of late life cognitive impairment. Neurobiol Aging. 2015 Jul; 36(7):2225-2231.
    View in: PubMed
    Score: 0.053
  400. A novel Alzheimer disease locus located near the gene encoding tau protein. Mol Psychiatry. 2016 Jan; 21(1):108-17.
    View in: PubMed
    Score: 0.052
  401. A TREM1 variant alters the accumulation of Alzheimer-related amyloid pathology. Ann Neurol. 2015 Mar; 77(3):469-77.
    View in: PubMed
    Score: 0.052
  402. MIND diet associated with reduced incidence of Alzheimer's disease. Alzheimers Dement. 2015 Sep; 11(9):1007-14.
    View in: PubMed
    Score: 0.052
  403. Rarity of the Alzheimer disease-protective APP A673T variant in the United States. JAMA Neurol. 2015 Feb; 72(2):209-16.
    View in: PubMed
    Score: 0.052
  404. Association of Alzheimer's disease GWAS loci with MRI markers of brain aging. Neurobiol Aging. 2015 Apr; 36(4):1765.e7-1765.e16.
    View in: PubMed
    Score: 0.051
  405. Intranasal Delivery of NEMO-Binding Domain Peptide Prevents Memory Loss in a Mouse Model of Alzheimer's Disease. J Alzheimers Dis. 2015; 47(2):385-402.
    View in: PubMed
    Score: 0.051
  406. Calibrating longitudinal cognition in Alzheimer's disease across diverse test batteries and datasets. Neuroepidemiology. 2014; 43(3-4):194-205.
    View in: PubMed
    Score: 0.051
  407. 24-hour rhythms of DNA methylation and their relation with rhythms of RNA expression in the human dorsolateral prefrontal cortex. PLoS Genet. 2014 Nov; 10(11):e1004792.
    View in: PubMed
    Score: 0.051
  408. Subsets of a large cognitive battery better power clinical trials on early stage Alzheimer's disease. Neuroepidemiology. 2014; 43(2):131-9.
    View in: PubMed
    Score: 0.051
  409. Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study. JAMA Neurol. 2014 Nov; 71(11):1394-404.
    View in: PubMed
    Score: 0.051
  410. P300 Amplitude in Alzheimer's Disease: A Meta-Analysis and Meta-Regression. Clin EEG Neurosci. 2016 Jan; 47(1):48-55.
    View in: PubMed
    Score: 0.050
  411. Genome-wide association meta-analysis of neuropathologic features of Alzheimer's disease and related dementias. PLoS Genet. 2014 Sep; 10(9):e1004606.
    View in: PubMed
    Score: 0.050
  412. Two rare AKAP9 variants are associated with Alzheimer's disease in African Americans. Alzheimers Dement. 2014 Nov; 10(6):609-618.e11.
    View in: PubMed
    Score: 0.050
  413. Sleep is related to neuron numbers in the ventrolateral preoptic/intermediate nucleus in older adults with and without Alzheimer's disease. Brain. 2014 Oct; 137(Pt 10):2847-61.
    View in: PubMed
    Score: 0.050
  414. Methylomic profiling implicates cortical deregulation of ANK1 in Alzheimer's disease. Nat Neurosci. 2014 Sep; 17(9):1164-70.
    View in: PubMed
    Score: 0.050
  415. Alzheimer's disease: a comprehensive approach to patient management. Geriatrics. 1994 Aug; 49(8):20-6.
    View in: PubMed
    Score: 0.050
  416. At the interface of sensory and motor dysfunctions and Alzheimer's disease. Alzheimers Dement. 2015 Jan; 11(1):70-98.
    View in: PubMed
    Score: 0.050
  417. Fragile X gene expansions are not associated with dementia. Neurobiol Aging. 2014 Nov; 35(11):2637-2638.
    View in: PubMed
    Score: 0.049
  418. Associations of cerebrovascular and Alzheimer's disease pathology with brain atrophy. Curr Alzheimer Res. 2014 May; 11(4):309-16.
    View in: PubMed
    Score: 0.049
  419. White matter changes: neurobehavioral manifestations of Binswanger's disease and clinical correlates in Alzheimer's disease. Dementia. 1994 May-Aug; 5(3-4):148-52.
    View in: PubMed
    Score: 0.049
  420. An empirically derived composite cognitive test score with improved power to track and evaluate treatments for preclinical Alzheimer's disease. Alzheimers Dement. 2014 Nov; 10(6):666-74.
    View in: PubMed
    Score: 0.049
  421. REST and stress resistance in ageing and Alzheimer's disease. Nature. 2014 03 27; 507(7493):448-54.
    View in: PubMed
    Score: 0.049
  422. Age-specific incidence rates for dementia and Alzheimer disease in NIA-LOAD/NCRAD and EFIGA families: National Institute on Aging Genetics Initiative for Late-Onset Alzheimer Disease/National Cell Repository for Alzheimer Disease (NIA-LOAD/NCRAD) and Estudio Familiar de Influencia Genetica en Alzheimer (EFIGA). JAMA Neurol. 2014 Mar; 71(3):315-23.
    View in: PubMed
    Score: 0.049
  423. Advances in the prevention of Alzheimer's disease and dementia. J Intern Med. 2014 Mar; 275(3):229-50.
    View in: PubMed
    Score: 0.049
  424. Brain tocopherols related to Alzheimer's disease neuropathology in humans. Alzheimers Dement. 2015 Jan; 11(1):32-9.
    View in: PubMed
    Score: 0.049
  425. Ex vivo T2 relaxation: associations with age-related neuropathology and cognition. Neurobiol Aging. 2014 Jul; 35(7):1549-61.
    View in: PubMed
    Score: 0.048
  426. CD33: increased inclusion of exon 2 implicates the Ig V-set domain in Alzheimer's disease susceptibility. Hum Mol Genet. 2014 May 15; 23(10):2729-36.
    View in: PubMed
    Score: 0.048
  427. Age at surgical menopause influences cognitive decline and Alzheimer pathology in older women. Neurology. 2014 Jan 21; 82(3):222-9.
    View in: PubMed
    Score: 0.048
  428. Reply to Itzhaki and Klapper. J Infect Dis. 2014 Mar; 209(6):974.
    View in: PubMed
    Score: 0.048
  429. Pathological changes in frontal cortex from biopsy to autopsy in Alzheimer's disease. Neurobiol Aging. 1993 Nov-Dec; 14(6):589-96.
    View in: PubMed
    Score: 0.047
  430. The SORL1 gene and convergent neural risk for Alzheimer's disease across the human lifespan. Mol Psychiatry. 2014 Oct; 19(10):1125-32.
    View in: PubMed
    Score: 0.047
  431. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet. 2013 Dec; 45(12):1452-8.
    View in: PubMed
    Score: 0.047
  432. Resilient brain aging: characterization of discordance between Alzheimer's disease pathology and cognition. Curr Alzheimer Res. 2013 Oct; 10(8):844-51.
    View in: PubMed
    Score: 0.047
  433. Cerebrospinal fluid tau cleaved by caspase-6 reflects brain levels and cognition in aging and Alzheimer disease. J Neuropathol Exp Neurol. 2013 Sep; 72(9):824-32.
    View in: PubMed
    Score: 0.047
  434. The PSEN1, p.E318G variant increases the risk of Alzheimer's disease in APOE-e4 carriers. PLoS Genet. 2013; 9(8):e1003685.
    View in: PubMed
    Score: 0.047
  435. Much of late life cognitive decline is not due to common neurodegenerative pathologies. Ann Neurol. 2013 Sep; 74(3):478-89.
    View in: PubMed
    Score: 0.046
  436. PAK inactivation impairs social recognition in 3xTg-AD Mice without increasing brain deposition of tau and A?. J Neurosci. 2013 Jun 26; 33(26):10729-40.
    View in: PubMed
    Score: 0.046
  437. CD33 Alzheimer's disease locus: altered monocyte function and amyloid biology. Nat Neurosci. 2013 Jul; 16(7):848-50.
    View in: PubMed
    Score: 0.046
  438. Virological and immunological characteristics of human cytomegalovirus infection associated with Alzheimer disease. J Infect Dis. 2013 Aug 15; 208(4):564-72.
    View in: PubMed
    Score: 0.046
  439. Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer's disease. Cell. 2013 Apr 25; 153(3):707-20.
    View in: PubMed
    Score: 0.046
  440. Variants in the ATP-binding cassette transporter (ABCA7), apolipoprotein E ?4,and the risk of late-onset Alzheimer disease in African Americans. JAMA. 2013 Apr 10; 309(14):1483-92.
    View in: PubMed
    Score: 0.046
  441. Brain amyloid-? oligomers in ageing and Alzheimer's disease. Brain. 2013 May; 136(Pt 5):1383-98.
    View in: PubMed
    Score: 0.046
  442. GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease. Neuron. 2013 Apr 24; 78(2):256-68.
    View in: PubMed
    Score: 0.046
  443. Genome-wide association study of the rate of cognitive decline in Alzheimer's disease. Alzheimers Dement. 2014 Jan; 10(1):45-52.
    View in: PubMed
    Score: 0.046
  444. AD pathology and cerebral infarctions are associated with memory and executive functioning one and five years before death. J Clin Exp Neuropsychol. 2013; 35(1):24-34.
    View in: PubMed
    Score: 0.045
  445. The complex PrP(c)-Fyn couples human oligomeric A? with pathological tau changes in Alzheimer's disease. J Neurosci. 2012 Nov 21; 32(47):16857-71a.
    View in: PubMed
    Score: 0.044
  446. GBA mutations increase risk for Lewy body disease with and without Alzheimer disease pathology. Neurology. 2012 Nov 06; 79(19):1944-50.
    View in: PubMed
    Score: 0.044
  447. Relation of neuropathology to cognition in persons without cognitive impairment. Ann Neurol. 2012 Oct; 72(4):599-609.
    View in: PubMed
    Score: 0.044
  448. Soluble a-synuclein is a novel modulator of Alzheimer's disease pathophysiology. J Neurosci. 2012 Jul 25; 32(30):10253-66.
    View in: PubMed
    Score: 0.043
  449. Novel late-onset Alzheimer disease loci variants associate with brain gene expression. Neurology. 2012 Jul 17; 79(3):221-8.
    View in: PubMed
    Score: 0.043
  450. Dementia from Alzheimer disease and mixed pathologies in the oldest old. JAMA. 2012 May 02; 307(17):1798-800.
    View in: PubMed
    Score: 0.043
  451. Alzheimer disease susceptibility loci: evidence for a protein network under natural selection. Am J Hum Genet. 2012 Apr 06; 90(4):720-6.
    View in: PubMed
    Score: 0.043
  452. Terminal dedifferentiation of cognitive abilities. Neurology. 2012 Apr 10; 78(15):1116-22.
    View in: PubMed
    Score: 0.043
  453. Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. J Clin Invest. 2012 Apr; 122(4):1316-38.
    View in: PubMed
    Score: 0.043
  454. Clinical correlates of high signal lesions on magnetic resonance imaging in Alzheimer's disease. J Neurol. 1992 Apr; 239(4):186-90.
    View in: PubMed
    Score: 0.043
  455. Plasma biomarkers of depressive symptoms in older adults. Transl Psychiatry. 2012 Jan 03; 2:e65.
    View in: PubMed
    Score: 0.042
  456. Alzheimer's disease. Dis Mon. 1992 Jan; 38(1):1-64.
    View in: PubMed
    Score: 0.042
  457. Altered NEP2 expression and activity in mild cognitive impairment and Alzheimer's disease. J Alzheimers Dis. 2012; 28(2):433-41.
    View in: PubMed
    Score: 0.042
  458. Correlation of amyloid PET ligand florbetapir F 18 binding with A? aggregation and neuritic plaque deposition in postmortem brain tissue. Alzheimer Dis Assoc Disord. 2012 Jan-Mar; 26(1):8-16.
    View in: PubMed
    Score: 0.042
  459. Plasma and brain fatty acid profiles in mild cognitive impairment and Alzheimer's disease. J Alzheimers Dis. 2012; 29(3):691-7.
    View in: PubMed
    Score: 0.042
  460. A genome-wide scan for common variants affecting the rate of age-related cognitive decline. Neurobiol Aging. 2012 May; 33(5):1017.e1-15.
    View in: PubMed
    Score: 0.041
  461. Functional links between A? toxicity, endocytic trafficking, and Alzheimer's disease risk factors in yeast. Science. 2011 Dec 02; 334(6060):1241-5.
    View in: PubMed
    Score: 0.041
  462. Accumulation of transactive response DNA binding protein 43 in mild cognitive impairment and Alzheimer disease. J Neuropathol Exp Neurol. 2011 Sep; 70(9):788-98.
    View in: PubMed
    Score: 0.041
  463. ELISA measurement of specific non-antigen-bound antibodies to A?1-42 monomer and soluble oligomers in sera from Alzheimer's disease, mild cognitively impaired, and noncognitively impaired subjects. J Neuroinflammation. 2011 Aug 09; 8:93.
    View in: PubMed
    Score: 0.041
  464. A life course model of cognitive activities, socioeconomic status, education, reading ability, and cognition. J Am Geriatr Soc. 2011 Aug; 59(8):1403-11.
    View in: PubMed
    Score: 0.041
  465. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke. 2011 Sep; 42(9):2672-713.
    View in: PubMed
    Score: 0.041
  466. Body mass index is associated with biological CSF markers of core brain pathology of Alzheimer's disease. Neurobiol Aging. 2012 Aug; 33(8):1599-608.
    View in: PubMed
    Score: 0.040
  467. Altered ryanodine receptor expression in mild cognitive impairment and Alzheimer's disease. Neurobiol Aging. 2012 May; 33(5):1001.e1-6.
    View in: PubMed
    Score: 0.040
  468. Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011 May; 7(3):280-92.
    View in: PubMed
    Score: 0.040
  469. Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet. 2011 May; 43(5):436-41.
    View in: PubMed
    Score: 0.040
  470. CR1 is associated with amyloid plaque burden and age-related cognitive decline. Ann Neurol. 2011 Mar; 69(3):560-9.
    View in: PubMed
    Score: 0.039
  471. Genome-wide association of familial late-onset Alzheimer's disease replicates BIN1 and CLU and nominates CUGBP2 in interaction with APOE. PLoS Genet. 2011 Feb; 7(2):e1001308.
    View in: PubMed
    Score: 0.039
  472. Functional screening of Alzheimer pathology genome-wide association signals in Drosophila. Am J Hum Genet. 2011 Feb 11; 88(2):232-8.
    View in: PubMed
    Score: 0.039
  473. Lewy bodies and olfactory dysfunction in old age. Chem Senses. 2011 May; 36(4):367-73.
    View in: PubMed
    Score: 0.039
  474. Hallucinations and associated factors in Alzheimer's disease. J Neuropsychiatry Clin Neurosci. 1991; 3(4):371-6.
    View in: PubMed
    Score: 0.039
  475. Reducing case ascertainment costs in U.S. population studies of Alzheimer's disease, dementia, and cognitive impairment-Part 1. Alzheimers Dement. 2011 Jan; 7(1):94-109.
    View in: PubMed
    Score: 0.039
  476. Clinical diagnosis of Binswanger's disease. J Neurol Neurosurg Psychiatry. 1990 Nov; 53(11):961-5.
    View in: PubMed
    Score: 0.039
  477. Change in risk of Alzheimer disease over time. Neurology. 2010 Aug 31; 75(9):786-91.
    View in: PubMed
    Score: 0.038
  478. Meta-analysis confirms CR1, CLU, and PICALM as alzheimer disease risk loci and reveals interactions with APOE genotypes. Arch Neurol. 2010 Dec; 67(12):1473-84.
    View in: PubMed
    Score: 0.038
  479. Expression and functional profiling of neprilysin, insulin-degrading enzyme, and endothelin-converting enzyme in prospectively studied elderly and Alzheimer's brain. J Neurochem. 2010 Oct; 115(1):47-57.
    View in: PubMed
    Score: 0.038
  480. Telephone assessment of cognitive function in the late-onset Alzheimer's disease family study. Arch Neurol. 2010 Jul; 67(7):855-61.
    View in: PubMed
    Score: 0.038
  481. Intermediate phenotypes identify divergent pathways to Alzheimer's disease. PLoS One. 2010 Jun 21; 5(6):e11244.
    View in: PubMed
    Score: 0.038
  482. Association of CR1, CLU and PICALM with Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals. Hum Mol Genet. 2010 Aug 15; 19(16):3295-301.
    View in: PubMed
    Score: 0.037
  483. Alzheimer disease pathology in cognitively healthy elderly: a genome-wide study. Neurobiol Aging. 2011 Dec; 32(12):2113-22.
    View in: PubMed
    Score: 0.037
  484. Identification of Caspase-6-mediated processing of the valosin containing protein (p97) in Alzheimer's disease: a novel link to dysfunction in ubiquitin proteasome system-mediated protein degradation. J Neurosci. 2010 Apr 28; 30(17):6132-42.
    View in: PubMed
    Score: 0.037
  485. Assessment and familial aggregation of psychosis in Alzheimer's disease from the National Institute on Aging Late Onset Alzheimer's Disease Family Study. Brain. 2010 Apr; 133(Pt 4):1155-62.
    View in: PubMed
    Score: 0.037
  486. Brain sterol dysregulation in sporadic AD and MCI: relationship to heme oxygenase-1. J Neurochem. 2009 Aug; 110(4):1241-53.
    View in: PubMed
    Score: 0.035
  487. Early risk assessment for Alzheimer's disease. Alzheimers Dement. 2009 Mar; 5(2):182-96.
    View in: PubMed
    Score: 0.034
  488. Sirtuin 1 reduction parallels the accumulation of tau in Alzheimer disease. J Neuropathol Exp Neurol. 2009 Jan; 68(1):48-58.
    View in: PubMed
    Score: 0.034
  489. The neuropathology of older persons with and without dementia from community versus clinic cohorts. J Alzheimers Dis. 2009; 18(3):691-701.
    View in: PubMed
    Score: 0.034
  490. Phosphorylation of the translation initiation factor eIF2alpha increases BACE1 levels and promotes amyloidogenesis. Neuron. 2008 Dec 26; 60(6):988-1009.
    View in: PubMed
    Score: 0.034
  491. Caspase-3 is enriched in postsynaptic densities and increased in Alzheimer's disease. Am J Pathol. 2008 Nov; 173(5):1488-95.
    View in: PubMed
    Score: 0.033
  492. Rate of entorhinal and hippocampal atrophy in incipient and mild AD: relation to memory function. Neurobiol Aging. 2010 Jul; 31(7):1089-98.
    View in: PubMed
    Score: 0.033
  493. Cognitive performance correlates with cortical isopeptide immunoreactivity as well as Alzheimer type pathology. J Alzheimers Dis. 2008 Feb; 13(1):53-66.
    View in: PubMed
    Score: 0.032
  494. Sex-dependent association of a common low-density lipoprotein receptor polymorphism with RNA splicing efficiency in the brain and Alzheimer's disease. Hum Mol Genet. 2008 Apr 01; 17(7):929-35.
    View in: PubMed
    Score: 0.032
  495. Biochemical characterization of Abeta and tau pathologies in mild cognitive impairment and Alzheimer's disease. J Alzheimers Dis. 2007 Dec; 12(4):377-90.
    View in: PubMed
    Score: 0.031
  496. Estimation of the mediation effect with a binary mediator. Stat Med. 2007 Aug 15; 26(18):3398-414.
    View in: PubMed
    Score: 0.031
  497. Olfactory identification and incidence of mild cognitive impairment in older age. Arch Gen Psychiatry. 2007 Jul; 64(7):802-8.
    View in: PubMed
    Score: 0.031
  498. Brain erythropoietin receptor expression in Alzheimer disease and mild cognitive impairment. J Neuropathol Exp Neurol. 2007 May; 66(5):389-98.
    View in: PubMed
    Score: 0.030
  499. Activation of caspase-6 in aging and mild cognitive impairment. Am J Pathol. 2007 Apr; 170(4):1200-9.
    View in: PubMed
    Score: 0.030
  500. The significance of Pin1 in the development of Alzheimer's disease. J Alzheimers Dis. 2007 Mar; 11(1):13-23.
    View in: PubMed
    Score: 0.030
  501. Lack of association of hepatic lipase polymorphisms with late-onset Alzheimer's disease. Neurobiol Aging. 2008 May; 29(5):793-4.
    View in: PubMed
    Score: 0.029
  502. ADCS Prevention Instrument Project: assessment of instrumental activities of daily living for community-dwelling elderly individuals in dementia prevention clinical trials. Alzheimer Dis Assoc Disord. 2006 Oct-Dec; 20(4 Suppl 3):S152-69.
    View in: PubMed
    Score: 0.029
  503. Hippocampal disconnection contributes to memory dysfunction in individuals at risk for Alzheimer's disease. Proc Natl Acad Sci U S A. 2006 Jun 27; 103(26):10041-5.
    View in: PubMed
    Score: 0.028
  504. Early involvement of small inhibitory cortical interneurons in Alzheimer's disease. Acta Neuropathol. 2006 Aug; 112(2):147-62.
    View in: PubMed
    Score: 0.028
  505. The relation of cigarette smoking to incident Alzheimer's disease in a biracial urban community population. Neuroepidemiology. 2006; 26(3):140-6.
    View in: PubMed
    Score: 0.028
  506. The amyloid pathology progresses in a neurotransmitter-specific manner. Neurobiol Aging. 2006 Nov; 27(11):1644-57.
    View in: PubMed
    Score: 0.027
  507. Hallucinations and mortality in Alzheimer disease. Am J Geriatr Psychiatry. 2005 Nov; 13(11):984-90.
    View in: PubMed
    Score: 0.027
  508. Change in cognitive function in Alzheimer's disease in African-American and white persons. Neuroepidemiology. 2006; 26(1):16-22.
    View in: PubMed
    Score: 0.027
  509. Biomarker discovery and analysis platform: application to Alzheimer's disease. Biotechniques. 2005 Oct; 39(4):606-7.
    View in: PubMed
    Score: 0.027
  510. The Rush Memory and Aging Project: study design and baseline characteristics of the study cohort. Neuroepidemiology. 2005; 25(4):163-75.
    View in: PubMed
    Score: 0.027
  511. High-resolution serum proteomic profiling of Alzheimer disease samples reveals disease-specific, carrier-protein-bound mass signatures. Clin Chem. 2005 Oct; 51(10):1946-54.
    View in: PubMed
    Score: 0.027
  512. White matter changes in mild cognitive impairment and AD: A diffusion tensor imaging study. Neurobiol Aging. 2006 May; 27(5):663-72.
    View in: PubMed
    Score: 0.027
  513. Detailed assessment of activities of daily living in moderate to severe Alzheimer's disease. J Int Neuropsychol Soc. 2005 Jul; 11(4):446-53.
    View in: PubMed
    Score: 0.027
  514. MRI predictors of risk of incident Alzheimer disease: a longitudinal study. Neurology. 2005 May 10; 64(9):1520-4.
    View in: PubMed
    Score: 0.026
  515. Glial heme oxygenase-1 expression in Alzheimer disease and mild cognitive impairment. Neurobiol Aging. 2006 Feb; 27(2):252-61.
    View in: PubMed
    Score: 0.026
  516. Genetic variation in the brain derived neurotrophic factor gene in Alzheimer's disease. Am J Med Genet B Neuropsychiatr Genet. 2005 Apr 05; 134B(1):1-5.
    View in: PubMed
    Score: 0.026
  517. The apolipoprotein E epsilon4 allele increases the odds of chronic cerebral infarction [corrected] detected at autopsy in older persons. Stroke. 2005 May; 36(5):954-9.
    View in: PubMed
    Score: 0.026
  518. Reduction of choline acetyltransferase activity in primary visual cortex in mild to moderate Alzheimer's disease. Arch Neurol. 2005 Mar; 62(3):425-30.
    View in: PubMed
    Score: 0.026
  519. Lack of genetic association of cholesteryl ester transfer protein polymorphisms with late onset Alzheimers disease. Neurosci Lett. 2005 Jun 10-17; 381(1-2):36-41.
    View in: PubMed
    Score: 0.026
  520. Proneness to psychological distress and risk of Alzheimer disease in a biracial community. Neurology. 2005 Jan 25; 64(2):380-2.
    View in: PubMed
    Score: 0.026
  521. Genetic association of low density lipoprotein receptor and Alzheimer's disease. Neurobiol Aging. 2005 Jan; 26(1):1-7.
    View in: PubMed
    Score: 0.026
  522. Assessment of cognitive decline in old age with brief tests amenable to telephone administration. Neuroepidemiology. 2005; 25(1):19-25.
    View in: PubMed
    Score: 0.026
  523. A longitudinal study of implicit and explicit memory in old persons. Psychol Aging. 2004 Dec; 19(4):617-25.
    View in: PubMed
    Score: 0.026
  524. MRI-derived entorhinal volume is a good predictor of conversion from MCI to AD. Neurobiol Aging. 2004 Oct; 25(9):1197-203.
    View in: PubMed
    Score: 0.025
  525. Early N-terminal changes and caspase-6 cleavage of tau in Alzheimer's disease. J Neurosci. 2004 Sep 08; 24(36):7895-902.
    View in: PubMed
    Score: 0.025
  526. Dietary niacin and the risk of incident Alzheimer's disease and of cognitive decline. J Neurol Neurosurg Psychiatry. 2004 Aug; 75(8):1093-9.
    View in: PubMed
    Score: 0.025
  527. Microscale fractionation facilitates detection of differentially expressed proteins in Alzheimer's disease brain samples. Electrophoresis. 2004 Aug; 25(15):2557-63.
    View in: PubMed
    Score: 0.025
  528. Influence of behavioral symptoms on rates of institutionalization for persons with Alzheimer's disease. Psychol Med. 2004 Aug; 34(6):1129-35.
    View in: PubMed
    Score: 0.025
  529. State-specific projections through 2025 of Alzheimer disease prevalence. Neurology. 2004 May 11; 62(9):1645.
    View in: PubMed
    Score: 0.025
  530. Cerebral infarctions and the relationship of depression symptoms to level of cognitive functioning in older persons. Am J Geriatr Psychiatry. 2004 Mar-Apr; 12(2):211-9.
    View in: PubMed
    Score: 0.024
  531. Predictors of depressive symptoms in persons with Alzheimer's disease. J Gerontol B Psychol Sci Soc Sci. 2004 Mar; 59(2):P75-83.
    View in: PubMed
    Score: 0.024
  532. Premorbid proneness to distress and episodic memory impairment in Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2004 Feb; 75(2):191-5.
    View in: PubMed
    Score: 0.024
  533. Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials. Arch Neurol. 2004 Jan; 61(1):59-66.
    View in: PubMed
    Score: 0.024
  534. Rate of cognitive decline and mortality in Alzheimer's disease. Neurology. 2003 Nov 25; 61(10):1356-61.
    View in: PubMed
    Score: 0.024
  535. Subicular dendritic arborization in Alzheimer's disease correlates with neurofibrillary tangle density. Am J Pathol. 2003 Oct; 163(4):1615-21.
    View in: PubMed
    Score: 0.024
  536. Design of the Chicago Health and Aging Project (CHAP). J Alzheimers Dis. 2003 Oct; 5(5):349-55.
    View in: PubMed
    Score: 0.024
  537. Alzheimer disease in the US population: prevalence estimates using the 2000 census. Arch Neurol. 2003 Aug; 60(8):1119-22.
    View in: PubMed
    Score: 0.023
  538. Preservation of brain nerve growth factor in mild cognitive impairment and Alzheimer disease. Arch Neurol. 2003 Aug; 60(8):1143-8.
    View in: PubMed
    Score: 0.023
  539. Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease. Arch Neurol. 2003 Jul; 60(7):940-6.
    View in: PubMed
    Score: 0.023
  540. Incidence of Alzheimer disease in a biracial urban community: relation to apolipoprotein E allele status. Arch Neurol. 2003 Feb; 60(2):185-9.
    View in: PubMed
    Score: 0.023
  541. Dietary fats and the risk of incident Alzheimer disease. Arch Neurol. 2003 Feb; 60(2):194-200.
    View in: PubMed
    Score: 0.023
  542. Cholinergic plasticity in hippocampus of individuals with mild cognitive impairment: correlation with Alzheimer's neuropathology. J Alzheimers Dis. 2003 Feb; 5(1):39-48.
    View in: PubMed
    Score: 0.023
  543. Cognitive activity and incident AD in a population-based sample of older persons. Neurology. 2002 Dec 24; 59(12):1910-4.
    View in: PubMed
    Score: 0.022
  544. Tau conformational changes correspond to impairments of episodic memory in mild cognitive impairment and Alzheimer's disease. Exp Neurol. 2002 Oct; 177(2):475-93.
    View in: PubMed
    Score: 0.022
  545. Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study. JAMA. 2002 Jun 26; 287(24):3230-7.
    View in: PubMed
    Score: 0.022
  546. Loss of basal forebrain P75(NTR) immunoreactivity in subjects with mild cognitive impairment and Alzheimer's disease. J Comp Neurol. 2002 Feb 04; 443(2):136-53.
    View in: PubMed
    Score: 0.021
  547. Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment. Ann Neurol. 2002 Feb; 51(2):145-55.
    View in: PubMed
    Score: 0.021
  548. Parahippocampal tau pathology in healthy aging, mild cognitive impairment, and early Alzheimer's disease. Ann Neurol. 2002 Feb; 51(2):182-9.
    View in: PubMed
    Score: 0.021
  549. Impaired production priming and intact identification priming in Alzheimer's disease. J Int Neuropsychol Soc. 2001 Nov; 7(7):785-94.
    View in: PubMed
    Score: 0.021
  550. Association of incident Alzheimer disease and blood pressure measured from 13 years before to 2 years after diagnosis in a large community study. Arch Neurol. 2001 Oct; 58(10):1640-6.
    View in: PubMed
    Score: 0.021
  551. MRI-derived entorhinal and hippocampal atrophy in incipient and very mild Alzheimer's disease. Neurobiol Aging. 2001 Sep-Oct; 22(5):747-54.
    View in: PubMed
    Score: 0.020
  552. Down-regulation of trkA mRNA within nucleus basalis neurons in individuals with mild cognitive impairment and Alzheimer's disease. J Comp Neurol. 2001 Aug 27; 437(3):296-307.
    View in: PubMed
    Score: 0.020
  553. Limbic-predominant age-related TDP-43 encephalopathy neuropathologic change and microvascular pathologies in community-dwelling older persons. Brain Pathol. 2021 05; 31(3):e12939.
    View in: PubMed
    Score: 0.020
  554. Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture. Nat Genet. 2021 03; 53(3):294-303.
    View in: PubMed
    Score: 0.020
  555. A? (Amyloid Beta) and Tau Tangle Pathology Modifies the Association Between Small Vessel Disease and Cortical Microinfarcts. Stroke. 2021 03; 52(3):1012-1021.
    View in: PubMed
    Score: 0.020
  556. Premorbid reading activity and patterns of cognitive decline in Alzheimer disease. Arch Neurol. 2000 Dec; 57(12):1718-23.
    View in: PubMed
    Score: 0.019
  557. Perceived Impediments to Completed Brain Autopsies Among Diverse Older Adults Who Have Signed a Uniform Anatomical Gift Act for Brain Donation for Clinical Research. Ethn Dis. 2020; 30(Suppl 2):709-718.
    View in: PubMed
    Score: 0.019
  558. Loss of nucleus basalis neurons containing trkA immunoreactivity in individuals with mild cognitive impairment and early Alzheimer's disease. J Comp Neurol. 2000 Nov 06; 427(1):19-30.
    View in: PubMed
    Score: 0.019
  559. Decline of language among women and men with Alzheimer's disease. J Gerontol B Psychol Sci Soc Sci. 2000 Nov; 55(6):P354-60.
    View in: PubMed
    Score: 0.019
  560. Peripheral serum metabolomic profiles inform central cognitive impairment. Sci Rep. 2020 08 20; 10(1):14059.
    View in: PubMed
    Score: 0.019
  561. Hallucinations, delusions, and cognitive decline in Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2000 Aug; 69(2):172-7.
    View in: PubMed
    Score: 0.019
  562. BIN1 protein isoforms are differentially expressed in astrocytes, neurons, and microglia: neuronal and astrocyte BIN1 are implicated in tau pathology. Mol Neurodegener. 2020 07 29; 15(1):44.
    View in: PubMed
    Score: 0.019
  563. Genetics of Gene Expression in the Aging Human Brain Reveal TDP-43 Proteinopathy Pathophysiology. Neuron. 2020 08 05; 107(3):496-508.e6.
    View in: PubMed
    Score: 0.019
  564. Progression of parkinsonism and loss of cognitive function in Alzheimer disease. Arch Neurol. 2000 Jun; 57(6):855-60.
    View in: PubMed
    Score: 0.019
  565. Total daily physical activity, brain pathologies, and parkinsonism in older adults. PLoS One. 2020; 15(4):e0232404.
    View in: PubMed
    Score: 0.019
  566. Progression of parkinsonian signs in Alzheimer's disease. Neurology. 2000 Mar 28; 54(6):1284-9.
    View in: PubMed
    Score: 0.018
  567. Person-specific paths of cognitive decline in Alzheimer's disease and their relation to age. Psychol Aging. 2000 Mar; 15(1):18-28.
    View in: PubMed
    Score: 0.018
  568. The cross-sectional association between blood pressure and Alzheimer's disease in a biracial community population of older persons. J Gerontol A Biol Sci Med Sci. 2000 Mar; 55(3):M130-6.
    View in: PubMed
    Score: 0.018
  569. Neuropathologic Correlates of White Matter Hyperintensities in a Community-Based Cohort of Older Adults. J Alzheimers Dis. 2020; 73(1):333-345.
    View in: PubMed
    Score: 0.018
  570. Genetic Factors of Alzheimer's Disease Modulate How Diet is Associated with Long-Term Cognitive Trajectories: A UK Biobank Study. J Alzheimers Dis. 2020; 78(3):1245-1257.
    View in: PubMed
    Score: 0.018
  571. Change in cognitive function in older persons from a community population: relation to age and Alzheimer disease. Arch Neurol. 1999 Oct; 56(10):1274-9.
    View in: PubMed
    Score: 0.018
  572. Frequency of the TREM2 R47H Variant in Various Neurodegenerative Disorders. Alzheimer Dis Assoc Disord. 2019 Oct-Dec; 33(4):327-330.
    View in: PubMed
    Score: 0.018
  573. Entorhinal cortex beta-amyloid load in individuals with mild cognitive impairment. Exp Neurol. 1999 Aug; 158(2):469-90.
    View in: PubMed
    Score: 0.018
  574. Somatic mosaicism of sex chromosomes in the blood and brain. Brain Res. 2019 10 15; 1721:146345.
    View in: PubMed
    Score: 0.018
  575. Healthcare and Financial Decision Making and Incident Adverse Cognitive Outcomes among Older Adults. J Am Geriatr Soc. 2019 08; 67(8):1590-1595.
    View in: PubMed
    Score: 0.017
  576. Associations of amygdala volume and shape with transactive response DNA-binding protein 43 (TDP-43) pathology in a community cohort of older adults. Neurobiol Aging. 2019 05; 77:104-111.
    View in: PubMed
    Score: 0.017
  577. Neuropathological correlates and genetic architecture of microglial activation in elderly human brain. Nat Commun. 2019 01 24; 10(1):409.
    View in: PubMed
    Score: 0.017
  578. Postmortem neurodegenerative markers and trajectories of decline in cognitive systems. Neurology. 2019 02 19; 92(8):e831-e840.
    View in: PubMed
    Score: 0.017
  579. Word-stem completion priming in healthy aging and Alzheimer's disease: the effects of age, cognitive status, and encoding. Neuropsychology. 1999 Jan; 13(1):22-30.
    View in: PubMed
    Score: 0.017
  580. Subtypes Based on Neuropsychological Performance Predict Incident Dementia: Findings from the Rush Memory and Aging Project. J Alzheimers Dis. 2019; 67(1):125-135.
    View in: PubMed
    Score: 0.017
  581. Vitamin E and vitamin C supplement use and risk of incident Alzheimer disease. Alzheimer Dis Assoc Disord. 1998 Sep; 12(3):121-6.
    View in: PubMed
    Score: 0.017
  582. Polygenic analysis of inflammatory disease variants and effects on microglia in the aging brain. Mol Neurodegener. 2018 07 24; 13(1):38.
    View in: PubMed
    Score: 0.016
  583. Neurodegenerative disease and cognitive retest learning. Neurobiol Aging. 2018 06; 66:122-130.
    View in: PubMed
    Score: 0.016
  584. Alzheimer's disease: in vivo detection of differential vulnerability of brain regions. Neurobiol Aging. 1997 Sep-Oct; 18(5):463-8.
    View in: PubMed
    Score: 0.015
  585. Selective lowering of synapsins induced by oligomeric a-synuclein exacerbates memory deficits. Proc Natl Acad Sci U S A. 2017 06 06; 114(23):E4648-E4657.
    View in: PubMed
    Score: 0.015
  586. Identification of genes associated with dissociation of cognitive performance and neuropathological burden: Multistep analysis of genetic, epigenetic, and transcriptional data. PLoS Med. 2017 04; 14(4):e1002287.
    View in: PubMed
    Score: 0.015
  587. Outcomes after diagnosis of mild cognitive impairment in a large autopsy series. Ann Neurol. 2017 Apr; 81(4):549-559.
    View in: PubMed
    Score: 0.015
  588. Susceptibility to neurofibrillary tangles: role of the PTPRD locus and limited pleiotropy with other neuropathologies. Mol Psychiatry. 2018 06; 23(6):1521-1529.
    View in: PubMed
    Score: 0.015
  589. Apolipoprotein E epsilon4 and incidence of Alzheimer disease in a community population of older persons. JAMA. 1997 Mar 12; 277(10):822-4.
    View in: PubMed
    Score: 0.015
  590. Weight loss in people with Alzheimer's disease: a prospective population based analysis. BMJ. 1997 Jan 18; 314(7075):178-9.
    View in: PubMed
    Score: 0.015
  591. Novel genetic loci associated with hippocampal volume. Nat Commun. 2017 01 18; 8:13624.
    View in: PubMed
    Score: 0.015
  592. An inventory to assess activities of daily living for clinical trials in Alzheimer's disease. The Alzheimer's Disease Cooperative Study. Alzheimer Dis Assoc Disord. 1997; 11 Suppl 2:S33-9.
    View in: PubMed
    Score: 0.015
  593. Why Alzheimer's disease is a women's health issue. J Am Med Womens Assoc (1972). 1997; 52(3):132-7.
    View in: PubMed
    Score: 0.015
  594. Postmortem MRI: a novel window into the neurobiology of late life cognitive decline. Neurobiol Aging. 2016 09; 45:169-177.
    View in: PubMed
    Score: 0.014
  595. Association of financial and health literacy with cognitive health in old age. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2017 Mar; 24(2):186-197.
    View in: PubMed
    Score: 0.014
  596. Genome-wide association study identifies 74 loci associated with educational attainment. Nature. 2016 05 26; 533(7604):539-42.
    View in: PubMed
    Score: 0.014
  597. Temporal course of neurodegenerative effects on cognition in old age. Neuropsychology. 2016 07; 30(5):591-9.
    View in: PubMed
    Score: 0.014
  598. Cerebrovascular and microglial states are not altered by functional neuroinflammatory gene variant. J Cereb Blood Flow Metab. 2016 Apr; 36(4):819-30.
    View in: PubMed
    Score: 0.014
  599. APOE and cerebral amyloid angiopathy in community-dwelling older persons. Neurobiol Aging. 2015 Nov; 36(11):2946-2953.
    View in: PubMed
    Score: 0.013
  600. Neuropathologic correlates of regional brain volumes in a community cohort of older adults. Neurobiol Aging. 2015 Oct; 36(10):2798-805.
    View in: PubMed
    Score: 0.013
  601. a-Synuclein pathology accumulates in sacral spinal visceral sensory pathways. Ann Neurol. 2015 Jul; 78(1):142-9.
    View in: PubMed
    Score: 0.013
  602. FASTKD2 is associated with memory and hippocampal structure in older adults. Mol Psychiatry. 2015 Oct; 20(10):1197-204.
    View in: PubMed
    Score: 0.013
  603. Interaction of transactive response DNA binding protein 43 with nuclear factor ?B in mild cognitive impairment with episodic memory deficits. Acta Neuropathol Commun. 2014 Apr 01; 2:37.
    View in: PubMed
    Score: 0.012
  604. Caspase-6 activity in the CA1 region of the hippocampus induces age-dependent memory impairment. Cell Death Differ. 2014 May; 21(5):696-706.
    View in: PubMed
    Score: 0.012
  605. Principal components methods for narrow-sense heritability in the analysis of multidimensional longitudinal cognitive phenotypes. Am J Med Genet B Neuropsychiatr Genet. 2013 Oct; 162B(7):770-8.
    View in: PubMed
    Score: 0.011
  606. Caspase-6 activity predicts lower episodic memory ability in aged individuals. Neurobiol Aging. 2013 Jul; 34(7):1815-24.
    View in: PubMed
    Score: 0.011
  607. APOE e4 increases risk for dementia in pure synucleinopathies. JAMA Neurol. 2013 Feb; 70(2):223-8.
    View in: PubMed
    Score: 0.011
  608. Genotype patterns at PICALM, CR1, BIN1, CLU, and APOE genes are associated with episodic memory. Neurology. 2012 May 08; 78(19):1464-71.
    View in: PubMed
    Score: 0.011
  609. Common variants at 12q14 and 12q24 are associated with hippocampal volume. Nat Genet. 2012 Apr 15; 44(5):545-51.
    View in: PubMed
    Score: 0.011
  610. A coding variant in CR1 interacts with APOE-e4 to influence cognitive decline. Hum Mol Genet. 2012 May 15; 21(10):2377-88.
    View in: PubMed
    Score: 0.011
  611. Genetic variation at CR1 increases risk of cerebral amyloid angiopathy. Neurology. 2012 Jan 31; 78(5):334-41.
    View in: PubMed
    Score: 0.010
  612. Predictors of behavioral disturbance in Alzheimer's disease. J Gerontol. 1991 Nov; 46(6):P362-71.
    View in: PubMed
    Score: 0.010
  613. Neuropathologic correlates of hippocampal atrophy in the elderly: a clinical, pathologic, postmortem MRI study. PLoS One. 2011; 6(10):e26286.
    View in: PubMed
    Score: 0.010
  614. Neuropathological associates of multiple cognitive functions in two community-based cohorts of older adults. J Int Neuropsychol Soc. 2011 Jul; 17(4):602-14.
    View in: PubMed
    Score: 0.010
  615. Cognitive activities during adulthood are more important than education in building reserve. J Int Neuropsychol Soc. 2011 Jul; 17(4):615-24.
    View in: PubMed
    Score: 0.010
  616. Microinfarct pathology, dementia, and cognitive systems. Stroke. 2011 Mar; 42(3):722-7.
    View in: PubMed
    Score: 0.010
  617. Induction of parkinsonism by intraventricular bethanechol in a patient with Alzheimer's disease. Neurology. 1989 Sep; 39(9):1265.
    View in: PubMed
    Score: 0.009
  618. Paradoxical upregulation of glutamatergic presynaptic boutons during mild cognitive impairment. J Neurosci. 2007 Oct 03; 27(40):10810-7.
    View in: PubMed
    Score: 0.008
  619. Contribution of changes in ubiquitin and myelin basic protein to age-related cognitive decline. Neurosci Res. 2004 Jan; 48(1):93-100.
    View in: PubMed
    Score: 0.006
  620. Cognitive activity and cognitive decline in a biracial community population. Neurology. 2003 Sep 23; 61(6):812-6.
    View in: PubMed
    Score: 0.006
  621. Novel method to quantify neuropil threads in brains from elders with or without cognitive impairment. J Histochem Cytochem. 2000 Dec; 48(12):1627-38.
    View in: PubMed
    Score: 0.005
  622. Preservation of nucleus basalis neurons containing choline acetyltransferase and the vesicular acetylcholine transporter in the elderly with mild cognitive impairment and early Alzheimer's disease. J Comp Neurol. 1999 Sep 06; 411(4):693-704.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.